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Neural cells constitute some of the most structurally diverse and complex cells in the 
body. Due to their relative inaccessibility, it remains a challenge to label and 
characterize neural cells effectively in their native settings. Traditionally, this has 
been achieved through the use of antibody staining or genetic intervention. Chemical 
genetics employs the use of small molecule probes to carry out effector functions 
without compromising cell viability and functionality. Using our Diversity Oriented 
Fluorescence Library (DOFL) of small molecule probes on a mouse primary neural 
cell screening platform, we have successfully identified several fluorescent 
compounds that are specific for microglia and neurons.  
 
Microglia are immune cells of the brain which play a critical role in protecting it 
against pathogen attack. The identification CDr10 as a microglia specific fluorescent 
dye enables us to monitor their presence and activity within the brain thus allows us 
to study their role in is in neurodegenerative and neuroinflammatory diseases. 
Neurons are responsible for the transmission of electrical signals that govern neural 
function. Our small molecule fluorescent dye, NeuO has the ability to stain live 
neurons selectively in vitro and in vivo thus providing us with a useful visualization 
and isolation tool. Because of their ability to transmit signals over long distances and 
form complex neural networks, tracing their morphology and connections within the 
nervous system has been of interest to researchers hoping to use this structure to 
delineate meaningful functional networks.  
 
Our microglia and neuron-specific fluorescent probes have been demonstrated to 
show specificity for their cell type of interest and are not detrimental to cellular 
function, thus facilitating their use in a variety of technical and clinical applications. 
Our neural stem cell specific dye, CDr3 was applied for sorting by Fluorescence 
Activated Cell Sorting, thus demonstrating a practical use for small molecules. In 
addition, these probes have the potential to be developed as in vivo tracers for the 
visualization of microglial or neuronal activity. This sets the field for a wide range of 
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1.1 Fundamentals of fluorescence 
Fluorescence is defined as the emission of light as a result of electrons falling 
from an elevated energy state. This can be illustrated by the Jablonski diagram 
(Figure 1.1.1), whereby electrons absorb light and are excited from ground states 
to higher energy triplet states. The loss of energy as a result of them falling from 
those higher energy triplet states is emitted in the form of fluorescence light [1].  
 
Figure 1.1.1. The Jablonski diagram. Image adapted from [2] 
Due to energy loss in the process of falling from higher energy states, which may 
be in the form of collision quenching or intersystem crossing, the final emitted 
photon is of a longer wavelength than its original absorption wavelength. This is 
known as the Stoke’s shift (See Figure 1.1.2 below). Electron excitation and 
emission is a cyclical process and a molecule will continue to emit fluorescence 
unless the fluorophore is destroyed or the energy is dissipated by other means. 
Alternatively, an excited S1 singlet state may be excited to triplet states by 
intersystem crossing. Its energy is subsequently lost by another decay process 





Figure 1.1.2. An example of excitation and emission spectral profiles. Image adapted 
from [4] 
The fluorescence Quantum Yield (QY) is defined as the number of fluorescent 
photons emitted per excitation photon absorbed [1]. The Extinction Coefficient (EC) 
for a fluorophore is defined as the capacity of a small molecule for light absorption at 
a specific wavelength. It is generally desirable for a fluorophore to have a higher EC 
to avoid effects such as photobleaching.  Fluorescence ‘output’ of the fluorophore i.e. 
brightness is thus proportional to the product of the extinction coefficient and 
fluorescence quantum yield. These measurements are critical for assessing the 
suitability of a fluorophore for its labelling purposes.  
Fluorescent proteins 
Nature has provided us with the most abundant sources of fluorescent material in the 
form of fluorescent proteins expressed in a wide range of organisms. The most 
popular Green Fluorescent Protein (GFP) was first discovered in the jellyfish, 
Aqueora victoria by Shimomura et al.[5] and has since become the benchmark for 
fluorescent protein expression and development. Modification to GFP and the 
subsequently discovered dsRed protein from the Discosoma coral protein sequences 
has enabled the development of a spectrum of multi-colour fluorescent proteins, 
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making them applicable for a variety of cell labelling and imaging methodologies 
(See Figure 1.1.3 below).  
 
Figure 1.1.3. The spectrum of fluorescent proteins available, most of which are 
derived from GFP and mRFP. Image adapted from [6]. 
Synthetic molecules scaffolds 
A large number of synthetic fluorescent molecule scaffolds are available 
commercially (Figure 1.1.4).  Like fluorescent proteins, they are available in different 
colours spanning the length of the visible light spectrum and modifications to 
chemical structure can alter their physicochemical properties. They are widely 
utilized for conjugation to antibodies or drug carriers for use as reporter markers.  
 
Figure 1.1.4 General structures of conventional fluorescent scaffolds for diversity-
oriented libraries. Arrows point at the approximate fluorescence emission 




1.2 Fluorescence imaging methods 
The effectiveness of fluorescence as a sensitive and quantitative feedback system has 
made it a popular tool in a variety of imaging and detection assay platforms. While 
fluorescence output is conventionally detected on a one dimensional platform using a 
spectrophotometer or fluorescence scanner, fluorescence microscopy has made it 
possible to visualize fluorescence labelled objects at high magnification in different 
colours.  
Fluorescence imaging requires illumination sources, which are usually in the form of 
arc lamps or lasers. Arc lamps such as xenon or mercury lamps are generally cheaper 
and have wider spectral characteristics but must be filtered to the desired wavelength 
[8]. In contrast, lasers have a more defined light pathway and provide brighter and 
more coherent sources of light, although separate lasers are required for specific 
excitation ranges. White tunable lasers have recently developed that can be adjusted 
to the desired wavelength. Their improved stability and durable will likely make them 
more popular excitation alternatives in future microscopy modules[8].  
Wide field vs confocal microscopy  
Wide field and confocal microscopy are the most common microscopy approaches. 
However each is distinct in its means of image acquisition and image information. 
Spatial resolution in all optical imaging set ups is limited by the wavelength of the 
light used and the numerical aperture (NA) of the objective lens, which is defined as: 
, where n is refraction index in the working medium and θ is 
the half angle of the maximum cone of light that can enter or exit the lens [3]. 
In the case of wide field microscopy, images are recorded over a series of focal 
planes to remove out of focus light [9]. However a downside of this setup is that 
secondary fluorescence emitted by the sample often obscures the resolution of the 





Figure 1.2.1. Difference between wide field and confocal microscope illumination. 
Image adapted from [10]. 
Confocal imaging represents an improved method of wide fluorescence imaging and 
is achieved by the elimination of out-of-focus rays through the addition of a pinhole 
positioned before the detector. Combined with laser scanning technology, this has 
enabled the improved resolution and image quality. However, proponents of wide 
field microscopy argue that the exclusion of the out-of-focus rays constitutes a loss of 
image information [9]. This in turn has spawned an array of different wide field and 
confocal imaging techniques such as structured illumination designed to circumvent 
some of the above mentioned issues [11] .  
Two-photon imaging 
Two-photon imaging has been an emerging imaging modality of note and is 
becoming increasingly popular for deep tissue imaging due to its reduced 
phototoxicity and increased penetration in the z axis (Figure 1.2.2) [12, 13]. Two-
photon imaging significantly improves image resolution in densely packed tissues 
such as brain slices which have a highly scattering environment. This is achieved by 
the use of two lower energy excitation beams, which when combined can produce the 
energy required to excite a fluorophore. As a result, only the point of interrogation is 




Figure 1.2.2. Two-photon imaging methodology for the brain surface as adapted 
from[12] 
Time lapse imaging 
Time lapse imaging can be achieved in all of the above mentioned settings and 
usually requires the configuration of an automated module on the microscope 
whereby images can be taken at defined time intervals over long durations (hours to 
days). Key considerations for time lapse imaging include the need for the 
incorporation of a humidifier and carbon dioxide chamber into the microscope set up 
to ensure cell survival over extended durations. Conditions must also be optimized to 
reduce light exposure and photobleaching.  
1.3 Methods of cellular fluorescence labelling 
Fluorescence labelling methods are an essential tool in biology for the identification 
and tracking of cells. Compared to conventional histological staining methods such as 
H & E and DAB staining, fluorescence labelling methods are quantitative and allow 
for multi- colour labelling with high sensitivity. It can be detected by a variety of 
readouts such as microscopes, cell sorters and spectrophotometers thus making it 
widely applicable to multiple methods of signal detection. Most of these fluorophores 
come in the form of antibody conjugates e.g. FITC, Cy5, AlexaFluor dyes. An 
alternative form of fluorescence labelling is by the creation of fluorescent protein 
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constructs such as the ubiquitous Green Fluorescent Protein (GFP) which has 
revolutionized the way researchers view and analyze cellular interactions. These two 
fluorescence labelling methods combined form the mainstay of cellular labelling 




Figure 1.3.1. Specific cellular labelling may be achieved using antibody fluorophore 
conjugates (left) or fluorescent protein expression (right) in target cell types. Author’s 
own illustration. 
However these methods are not without pitfalls. Antibody labelling of intracellular 
proteins requires that cells are fixed and permeabilized (i.e. dead) before the labelling 
can be visualized. As a result most existing studies are based on the observation of  
static images. Extracellular proteins while accessible are susceptible to cleavage by 
enzymes or other agents that the cell may be exposed to during sample preparation 
[14]. In the case of fluorophore conjugates, it is not unknown for the antibody to 
dissociate from its fluorophore or for fluorophore conjugates to detach after long term 
storage. This indirect method of labelling results in a loss of signal sensitivity making 
it difficult to accurately image the real time dynamics of some intracellular or 
extracellular protein labelled cells. Fluorescence protein expression, while useful and 
versatile can also lead to side effects such as loss of native protein function or cell 
activation [15].  The generation of transgenic animals that express the relevant 
reporter proteins is also a lengthy process. Real time live cell fluorescence imaging is 
critical in investigating and validating cellular activity, thus it is necessary to develop 





1.4 Chemical Genetics: The Diversity Oriented Fluorescence   
 Library 
Chemical methods of cellular labelling have become increasingly popular for site 
specific protein labelling. This can be achieved by a variety of methods such as 
chemical fusion protein tags or the incorporation of reactive amino acids into the 
protein backbone for selective reactions [16] (Figure 1.4.1). Many fluorescence 
labelling methods modify the endogenous structure of receptor-enzyme substrates to 
produce fluorescent substrate mimics. Examples included fluorescent dyes based on 
the structure of dopamine and acetylcholine [17, 18].  However most of these 
methods are not applicable for the labelling of native cellular proteins and direct 
labelling without perturbation to physiological systems is still the most desirable 
approach.  
 
Figure 1.4.1. Strategies for fluorescence tagging proteins. (a) Genetic fusion to a 
fluorescent protein requires the introduction of a large protein domain which may 
disrupt the system studied. (b) Chemical tag strategies use smaller protein fusions 
which use modular fluorescent dyes with different photophysical properties (c) The 
introduction of a reactive norborene amino acid into the backbone of the protein, 
which can then react selectively with tetrazines. (d) Direct incorporation of a 
fluorescent amino acid may still be the best way to tag proteins in live cells. As 




The Diversity Oriented Fluorescence Library (DOFL) is an approach developed by 
the laboratory of Professor Chang Young-Tae for the generation of fluorescent small 
molecules with diverse side chain structures based on different fluorescent molecule 
scaffolds (Figure 1.4.2).  This is achieved by the use of combinatorial chemistry for 
the synthesis of thousands of small molecules with varying side chain combinations 
creating a diverse pool of small molecule libraries. To date, his libraries comprise of 
up to 10,000 different compounds which may be applied for the screening of in vitro 
cell-based assays [20].  
 
Figure 1.4.2 Concept of combinatorial chemistry which is used as the basis for the 
generation of the DOFL. Author’s own illustration. 
These fluorescent small molecule libraries are then applied for cell or analyte 
screening. This approach which is known as the Diversity Oriented Fluorescence 
Library Approach (DOFLA) of reverse chemical genetics, involves the binding of a 
known chemical moiety to an unknown analyte/cellular target. The target can then be 
identified by tracing the fluorescence signal from the cellular lysate [21]. The cell 
staining mechanism of these dyes may largely be attributed to their hydrophobic 
nature, which leads to the formation of self-aggregates thereby quenching its 
inherently high quantum yield  [22]. Specific binding to the target molecule plausibly 
reverses this aggregated state, leading to fluorescent labeling. Major advantages of 
this approach are (1) the dye molecules are much smaller than conventional 
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antibodies or nanoparticles and can diffuse into the cell passively, (2) live cells can be 
stained, (3) higher chance of novel binding target discovery and (4) can be applied to 
different cell type specific screening platforms. Successful applications of this 
approach are exemplified in the development of the embryonic stem cell probe, 
CDy1[23] and the neural stem cell probe, CDr3 [24]. These small molecule probes 
are specific, versatile and can be used for a wide range of applications such as live 
cell imaging, cell sorting and even in vivo studies by the incorporation of radioactive 
atoms for molecular imaging.  
 
1.5 Application development of small molecule fluorescent 
probes 
In vitro  
Most small molecule discoveries are achieved by high throughput in vitro screens of 
thousands to millions of compounds from diverse chemical libraries. Their 
identification, validation and development to the in vivo or commercial stage require 
extensive testing and optimization. Thus far, small molecule fluorescent probes have 
seen their best utility in the live cell trackers and organelle specific markers as 
marketed by Life Technologies Corporation. These dyes are generally used for cell 
imaging applications and are mostly limited to in vitro applications. Not all of their 
binding targets are known but they remain invaluable tools in cellular imaging and 
are the benchmark for comparison in our own small molecule probe development.  
An ideal in vitro probe would possess the following characteristics - (1) be specific 
for the cell type of interest (2) be not cytotoxic (3) does not affect cellular function 
(4) have defined excitation/emission wavelengths and (5) produce stable, 
reproducible results. As a frame work for our probe development, we are keen to 
extend its application and utility beyond fluorescence live cell imaging. This includes 
development of applications such as cell isolation and monitoring of cell activation 
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status. The dyes may also be further assessed for target identification studies and 
suitability for in vivo testing. 
 
Figure 1.5.1. Time line for small molecule probe development (Author’s own) 
A major advantage of small molecule probes is their relatively small size (Mw<700), 
which enables them to enter cells easily. In the event whereby specific binding is 
observed, staining optimization is carried out to determine the most ideal 
concentration and conditions (e.g. media washing to remove background and improve 
contrast) for imaging. Comprehensive characterization with known markers of the 
cell type is also carried out. Depending on the staining properties of the small 
molecule, it may also be possible to carry out binding target identification and in vivo 
feasibility testing to determine if the dye can be developed for further applications.  
Small molecules are also extremely tunable. Structure Activity Relationships (SARs) 
studies can be used to identify critical motifs on the small molecules thereby allowing 
for chemical modifications on the less important side groups. Thus small molecules 
can be modified for strength of binding, fluorescent intensity, clogP value or the 
incorporation of chemical labelling tags. This is especially useful for the translation 
of probes to molecular imaging systems whereby the incorporation of radioactive 
atom such as Fluorine-18 (
18
F) converts the probe to a molecular imaging probe for 





An ideal application of small molecule probes discovered by in vitro screening is to 
translate them into in vivo imaging modalities for live animal imaging. Intravenous 
injection, whereby the probe is administered into the blood is still the mainstay of 
most translational whole animal probes, particularly for brain imaging. This requires 
the probe to travel to and penetrate the Blood Brain Barrier (BBB). The BBB is 
characterized by the extremely tight microvasculature governing the cells of the brain 
[26], thus limiting the size and properties of molecules able to reach the brain.  
Unfortunately despite extensive research and development, a large number of small 
molecules or drugs fail to accomplish the above despite their proven efficacy in vitro 
and never achieve clinical translation. 
While there are no hard and fast rules on the characteristics of potential BBB 
penetrating molecules, Lipinski’s rule of 5 still gives the best guidelines on the  
properties of an effective small molecule drug/probe.  The rule denotes that small 
molecules which have good drugability would ideally possess the following 
characteristics:  
(1) A molecular weight of less than 500 daltons 
(2) The compounds lipophilicity (Denoted by cLogP value, which is the logarithm of 
the partition coefficient between water and 1-octanol), is less than 5. 
(3)  The number of groups in the molecule that can donate hydrogen atoms to 
hydrogen bonds (usually the sum of hydroxyl and amine groups in a drug molecule) 
is less than 5. 
(4) The number of groups that can accept hydrogen atoms to form hydrogen bonds 
(estimated by the sum of oxygen and nitrogen atoms) is less than 10. 
Source: Drug discovery: Chemical beauty contest, Paul Leeson 
In the case of our small molecule probes, size and clogP values are particularly 
important. The dye must be small enough to penetrate the small gap junctions of the 
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BBB and hydrophobic enough to diffuse through the cell membrane to reach their 
targets. ClogP value is also critical because if the dye is not sufficiently lipophilic, it 
will pass through the tissues without binding but too lipophilic dyes may also get 
trapped in the lipid rich cells of the CNS and be prevented from reaching their targets. 
High non-specific binding to serum proteins also makes it unfeasible to administer 
the probe via intravenous means.  
 Dye formulation must also be optimized, especially if high concentrations of dye 
must be administered in small volumes. To circumvent this, additives such as Tween-
20 and Polyethylene Glycol (PEG) are often added to stabilize the dyes in solution. 
Additional pharmacokinetic and pharmacodynamic studies must also be carried out to 
ensure that the dye is not metabolized before it reaches its target organ nor have any 
potential physiologically adverse effects. At late stage development, particularly for 
the formulation of radioactive PET probes, the pharmacokinetic activity of the probe 
must also be synchronized with the half life of its radioactive entity such that binding 
and signal emission is achieved in a time window that is practical for clinical 
application [27]. Thus in addition to specificity, in vivo application of small molecule 
dyes requires additional formulation, which is formative in its translation from use in 
the cell to the whole animal.  
15 
 
Chapter 2:  
 
Methodology: 
Primary neural screening 
 
2.1  Aims & Objectives………………………………………... 16 
2.2 Overview of methodological approach ……………….… 17 
2.3 Screening design 
 [a] Mouse primary neural cell screening………………... 18 
 [b] Neuron and oligodendrocyte focused screen………... 19 
2.4 Hit compound selection, refinement and validation 
 Microglia hits……………………………………………….. 21 
 Neuron hits…………………………………………………. 22 
2.5 Target identification  
 Affinity based target identification methods………….….… 23 
 Non-affinity based target identification methods……..…… 25 








2.1 Aims & Objectives 
The rationale for the development of our Diversity Oriented Fluorescence Libraries is 
based on the hypothesis that the generation of diverse structures by modifying the 
side chains of diverse fluorescent scaffold such as BODIPY, rhodamine, coumarin, 
xanthone or styryl produces dyes that have the potential to bind specifically to targets 
of interest in cell or in vitro screening platforms of our design. This approach is more 
commonly termed the Reverse Chemical genetics approach, with its primary 
advantage being that it may lead to the discovery of novel targets.  
Neural cells represent challenging cell labelling targets due to the large size, 
heterogeneity and complexity of the brain, thus often requiring the desired cell types 
to be manually sorted out. However, many neural cell markers are intracellular, thus 
requiring cells to be permeabilized for antibody labelling. This limits the nature of 
downstream experiments that can be carried out and presents a significant barrier in 
our understanding of their function.  
My primary aim is to utilize the above system for the development of small molecule 
fluorescent probes specific for neural cells from mouse primary neural cells with 
focus on the four main cell types, namely Neurons, Astrocytes, Oligodendrocytes and 
Microglia. The goal is to identify cell type specific probes for one or more of the 








2.2. Overview of methodological approach 
High throughput image based screening with our DOFL was achieved using the high 
throughput image based screening system, known as ImageXpress as marketed by 
Molecular Devices (Figure 2.2.1). The cells were seeded in duplicate in a 384 well 
glass bottomed plate and stained with 500 nM of fluorescent dye. The choice of 500 
nM for most dyes was based on studies on other published dyes from the DOFL 
library [23, 24, 28], where 500 nM was generally found to be the most practical and 
optimal concentration of choice for BODIPY derivatives based on brightness and 
amount of dye required.  A total of 80 compounds were tested in duplicate on one 384 
well plate. Up to 5000 compounds in the DOFL library were screened for cell type 
selectivity. After image and intensity based analysis by multi-wavelength scoring, 
primary hit compounds were selected and re-screened in a secondary and 
subsequently tertiary screen. Further testing and validation were done by flow 
cytometry analysis and immunocytochemistry.   
 
Figure 2.2.1. Overview of screening methodology. (Author’s own.) 
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2.3 Screening design 
[a] Mouse primary neural cell screening 
For the set up of the mouse primary neural screen, we utilized neural cells harvested 
from P1-P3 mouse pup brains. The design of the screen is based on the premise that 
the cells of the brain can be segregated in to their different cell types for fluorescent 
probe discrimination. To achieve this, we employed an adapted differential adhesion 
method from Jana et al. which separated neurons, astrocytes and microglia based on 
their different preferences for cell coating surfaces [29]. Microglia have been reported 
to have a higher affinity for polystyrene culture dishes [30] whereas neurons adhere 
preferentially to poly-lysine coated dish surfaces [29]. Using these methods, we were 
able to isolate primary neurons, astrocytes and microglia at up to 80-90% purity as 
validated by immunostaining for the relevant cell type markers (Figure 2.3.1). Due to 
difficulties in obtaining oligodendrocyte yield, oligodendrocytes were omitted from 
the initial screen but were later included in a more focused neuron-oligodendrocyte 
screen that utilized neurosphere differentiation to achieve reasonable neuron and 




Figure 2.3.1. The above schematic illustrates the procedure for high throughput 
image based screening of microglia, astrocytes and neurons using compounds from 
our DOFL library. 
A total of 6 microglia hits and 1 neuron hit were shortlisted from primary, secondary 
and tertiary screening. We eventually chose to focus on two main cell type hits, 
Neuron Orange (NeuO) and Compound of Designation red (CDr10) which are 
specific for neurons and microglia respectively. 
[b] Neuron and oligodendrocyte screen 
In the absence of primary cells, neural stem cells form an alternative platform for the 
generation of neurons, astrocytes and oligodendrocytes. This is particularly useful for 
the generation of neuron or oligodendrocyte enriched cultures as these cells are 
harder to isolate in larger numbers from primary tissue. Neural stem cells can be 
expanded based on their ability to self renew and differentiated into the desired cell 
type of interest. For the purpose of screening and validation, several differentiation 
protocols for the generation of differentiated primary neurons and oligodendrocytes 
were adapted from published literature. 
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For the generation of oligodendrocytes from neurospheres, oligospheres were 
generated as described by Gibney et al [31]. Using this protocol, high percentages of 
O4 positive cells mature oligodendrocytes were generated (Figure 2.3.2, Left). The 
addition of BDNF has also been shown to promote neuronal differentiation [32]. To 
enrich for neurons, neurospheres were differentiated in serum containing media 
supplemented with 50 ng/ml of BDNF on poly-lysine coated surfaces. After 5-7 days 
of differentiation, cultures were shown to contain large number of GABAergic and 
Glutamatergic neurons. Generic differentiation conditions (serum containing media 
on poly-lysine) were also able to generate differentiated neurons, astrocytes and 
oligodendrocytes (Figure 2.3.2, Right) although the number of neurons and 
oligodendrocytes was markedly reduced under these conditions 
   
Figure 2.3.2. Left: Oligodendrocytes differentiated from oligospheres stained with 
O4 antibody. Middle: Neuron enriched cultures differentiated from BDNF treated 
neurospheres. Green (Neurons), Red (Astrocytes) and Blue (Nuclei). Right: Generic 
differentation of neurospheres in serum containing media generates all cell types, 











2.4 Hit compound selection, refinement and derivatives 
Microglia hits 
A total of 6 microglia hits were selected from screening (Figure 2.4.1, Appendix 
8.1.1). For the microglia hit, Compound of Designation red 10 binding (CDr10b) was 
selected as the final microglia selective compound. This was based on several factors, 
namely compound brightness, strength of binding and level of non-specific binding. 
Refinement on the choice of compound was measured by several parameters such as 
flow cytometry separation and image based analysis (See Appendix 8.1.1). Cell type 
specificity was also validated using antibodies specific for the cell of interest. A 
derivative of CDr10b, Compound of Designation 10 acetyl (CDr10a) was later 
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MKHA 101-3 was the first compound first identified for neuronal specificity (Figure 
2.4.2a). The structure of the molecule was later modified extensively to be developed 
to Neuron Orange (NeuO) as shown below, where it was identified that a 
modification of the chloroacetyl to a hydroxyl motif produced a marked improvement 
in the dyes specificity profile (Figure 2.4.2b and c). 
 
 
    
Figure 2.4.2 (a) Structures of MKCA 101-3 and MKHA 101-3 (b) Flow cytometry 
profiles of MKCA101-3 (left) and MKHA101-3 (right) stained mixed primary neural 
cell populations showing the neuronal population segregating from the main 
population based on compound fluorescence (red). Unstained controls are shown in 
blue. (c) Images of neurons derived from differentiated neurospheres. Both 
compounds stain the neurons but MKHA101-3 shows significantly improved 
specificity over MKCA101-3. Scale bar; 100 µm. 









2.5 Target identification  
A disadvantage of reverse chemical genetics lies in the fact that screening is carried 
out for an unknown target. Thus additional steps have to be undertaken to pull out 
and identify that target molecule before comprehensive SARs studies can be carried 
out. Identification of the target molecule is important because the binding site and its 
biological relevance is critical for further development of downstream applications in 
vitro and in vivo. An ideal probe should not interfere with physiological cellular 
functions such that it competes with or inhibits key interactions which may lead to 
serious side effects when administered in a clinical setting.  
Affinity-based target identification methods 
Affinity based target identification methods are based on the assumption that a 
covalent bond can be formed between the probe and a neighbouring target molecule 
or the target molecule itself by the introduction of reactive chemical groups. The most 
ideal target identification approach for small molecule fluorescent dyes are affinity-
matrix mediated. This requires the presence of a linker or tag molecule that will allow 
the binding molecule and its  covalently bound partner to be fished out [21]. These 
approaches can be categorized as fluorescence tag, on-bead, biotin tag, photoaffinity 
or chemical affinity. The choice of tag will depend on the nature of the binding 
strength to the target molecule and the flexibility of the lead compound structure to 
accommodate the incorporation of the respective tags. This is usually followed by 
column purification, SDS-PAGE separation and finally MALDI-TOF and MSMS 
methods.   
For fluorescence tagging, the method is straightforward. The intrinsic fluorescence of 
the binding compound can be followed by running SDS-PAGE protein gels and the 
protein band of interest excised based on its fluorescent signal and identified by mass 
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spectrometry. In the on-bead approach, prior SAR information is needed to determine 
a suitable position for linker modification. A solid phase matrix, usually in the form 
of agarose beads is then attached covalently to the small molecule and applied to the 
cell extract (Figure 2.5.1). The protein mixture is separated by SDS-PAGE gel 
chromatography and the target protein immobilized through the column, the isolated 
proteins are analysed by mass spectrometry after tryptic digestion. The corresponding 
peptides identified are then matched to their target proteins by data base searching.  
 
Figure 2.5.1. Illustration of target identification via the on-bead affinity matrix 
approach. Image from [21]. 
The biotin tag approach is similar to the on bead approach. Instead of introducing a 
covalent modification for the attachment of the solid phase matrix, the high biological 
affinity of biotin to streptavidin is utilized by incorporating biotin in the molecule 
structure and then pulling out the target protein from cell lysate using streptavidin 
conjugated beads. Protein identification is then achieved by the mass spectrometry 
methods as described above.  
Chemical and photoaffinity tagging involve the use of a photoaffinity or a chemical 
affinity moiety along with a reporter tag (Figure 2.5.2). The photoaffinity moiety 
makes the molecule very reactive upon UV irradiation, releasing a reactive carbene 
functional group that will enable covalent binding with nearby groups [33]. The target 
protein can subsequently be fished out and identified by the above mentioned mass 






Figure 2.5.2. Illustration of target identification via the chemical or photoaffinity 
matrix approach. Image from [21]. 
Non-affinity based target identification methods 
In the scenario whereby all of the above methods are unfeasible (i.e. chemical 
modification for affinity tags affects dye functionality and thus is not feasible for pull 
down), more complex and innovative methods are required for target identification. 
This is a particular concern for probes that exhibit weak binding and hence do not 
survive conventional protein separation and analysis techniques which are the 
prerequisite for mass spectrometry identification.  
2.6  Target validation 
In practical experience, the above target identification methods seldom give a single 
target protein result but rather a host of potential candidates which need to be 
carefully analysed for their relevance to the respective biological system used. Most 
of the above target validation approaches involve the pull down, separation and 
identification of proteins by mass spectrometry. However, the number of candidate 
target proteins identified will depend on the efficiency of protein pull down and 
separation. It is common to encounter multiple false positives which may be a 
product of non-specific binding or simply proteins that are very abundant or closely 
associated with the target. As such, a variety of methods are used to validate the 
target protein of interest including filtering based on mass size, cell localization and 





Overexpression, knockdown or knockout 
The most convincing methods for target validation involve the overexpression, 
knockdown or knock out of the target protein by modulation of cellular gene 
expression. For over expression, this is usually achieved by cloning of the gene of  
the target protein into expression vectors that produce it with a fluorescent protein 
(Figure 2.7.1) [34]. Cells transfected with the vector can then be treated with the 
small molecule of interest, which in our case is intrinsically fluorescent. Assuming 
we are on target, cells that over express the target protein will show stronger dye 
staining and co-localization with the fluorescent protein. A disadvantage of this 
approach is that not all proteins may be successfully expressed by commercial 
expression vectors  and they may exhibit non-native modifications that differ from 
the original protein [34]. As a result, the small molecule may no longer bind 
effectively to the target protein.  
                                                 
Figure 2.6.1. Left: A representative EGFP expression vector from Clontech. 
Neurofilment-GFP transfected HEK293 cells (cell image author’s own). Right: 
Schematic illustrating the knockdown/knockout of a target protein by siRNA. Image 




In knockdown or knockout experiments, the target gene of interest may be knocked 
down by siRNA methods, whereby a short RNA peptide sequence complementary to 
the target RNA transcript prevents translation and hence expression of the target 
protein (Figure 2.7.1). Thus using untreated cells as a control, cells that have the 
target protein knocked down should stain less effectively than the control cells when 
treated in parallel with the dye. However this approach is not without limitations. 
Depending on the biological importance of the protein, some proteins are difficult to 
knock out completely and one may only succeed in reducing protein expression. 
Owing to functional redundancy, others may require the knockdown of multiple gene 
sequences before a successful reduction in protein expression is achieved [36].  
Co-localization and pull down studies 
Studying the co-localization of the fluorescent binding molecule with known 
organellar and antibody markers is a useful indicator of whether we are on or off 
target and is often used to support target validation data. Utilizing known literature on 
the target protein, observations on cellular localization can be cross referenced with 
published studies. Commercially available fluorescent organelle trackers such as 
Mitotracker, Lysotracker and ER tracker from Life technologies may also be used to 
easily pinpoint the localization of the binding molecule. In an approach similar to 
over-expression, the target protein may also be FLAG tagged by cloning into the 
relevant expression vectors and pulled down by column purification or 
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3.1 Introduction to microglia 
Microglia form and function 
Microglia are resident immune cells of the brain that play a key role in a host of 
neuroinflammatory diseases. They differ from most other neural cells in the fact that 
they are derived from haematopoietic precursors during early embryogenesis and 
constitute approximately 5-10% of the brain cell population [37]. These cells respond 
dynamically to immunogenic stimulus by releasing a cascade of cytokines and 
migrating towards injured regions to actively phagocytose and destroy unwanted 
material [38].  
Microglia can be classified based on their morphology or activation state, with resting 
(inactive) microglia displaying a ramified morphology and active microglia 
displaying an amoeboid morphology [39] (Figure 3.1.1). In the presence of activating 
factors such as LPS challenge, resting microglia revert to their activated morphology 
and display characteristics such as increased proliferation and release of 
inflammatory cytokines such as IL-6 and TNF- [40]. 
 
Figure 3.1.1. Microglia change from a ramified to amoeboid morphology upon 








Microglia culture and isolation 
Microglia isolation is usually achieved by antibody labelling and sorting for 
extracellular markers such as CD11b [41]. Differential adhesion methods, which 
utilize the affinity of microglia to plastic surfaces [30] or density centrifugation 
methods [42] are also common methods for primary microglia cell isolation although 
cell yield remains limited due to the endogenously low percentage of microglia in the 
brain . Microglia cell lines such as the v-raf/v-myc retrovirus transformed murine 
microglial cell line, BV2 are thus popularly used to recapitulate properties of 
microglia in vitro [43]. Primary microglia can be subcultured and induced to grow 
more rapidly with the addition of factors such M-CSF or GM-CSF [44]. However 
studies suggest that in addition to aiding proliferation, these factors may also have an 
additional activating effect on microglia, which may be undesirable for downstream 
activation assays. As such, some assays recommend the use of astrocyte-conditioned 
media which provide the relevant growth factors for the cells without excessive cell 
activation [45].  
Microglia labelling methods 
Microglia are commonly imaged using the cell surface antibody markers such as Iba, 
CD11b, CD68, or isolectin B4 (Figure 3.1.2) [41]. The transgenic mouse, CX3CR1-
GFP is also a robust model for visualizing microglia activity in vitro or in vivo [46]. 
As microglia are derived from a haematopoietic lineage, they share many markers in 
common with monocytes and macrophages which will be discussed further below. 
                    
 
Figure 3.1.2. Methods of microglia labelling 
CX3CR1-GFP 
microglia, Author’s 
own image (Left) 
CD11b immunolabelled 
BV2 microglia, Tham    




The microglia – macrophage debate 
The haematopoietic lineage of microglia in the brain is of significant interest to 
researchers who are interested in the response of the native and infiltrating immune 
cells during BBB damage. Microglia are unique because unlike other cells of the 
brain, they migrate into the brain during early development [37] (Figure 3.1.3). 
However myeloid precursors from the blood/bone-marrow are known to migrate into 
the brain in response to damage to provide additional support to native microglia. 
 
Figure 3.1.3. Image from Saijo and Glass 2011, Nature reviews Immunology [47] 
At the moment, it is difficult to distinguish between the native microglia and myeloid 
cells that have entered the brain and differentiated into macrophages later in 
adulthood, the latter of which are associated with a more aggressive activator 
response during damage [48].  Studies suggest that some combinations of 
extracellular markers such as CCR2, Ly6G and CX3CR1 are able to distinguish these 






Microglia in disease 
Microglial localization and migration have also been of interest to researchers 
investigating their role in response to inflammation and neurodegenerative disease 
[51]. Studies have shown that the migration of microglia towards a tissue region 
precedes the tissue damage that takes place although their role in damage and repair 
remains controversial [52]. In view of this, considerable research has been focused on 
monitoring the activity of microglia in vivo. A popular in vivo molecular imaging 
marker of activated microglia is the PET probe, PK11195 which is commonly used 
for diagnostic imaging of neurodegenerative diseases such as Alzheimer’s [53] 
(Figure 3.1.4). The probe is an antagonist of the peripheral benzodiazepine receptor, 
known as TSPO and targets activated microglia. To date, all known microglia 
labelling probes have been modelled after the TSPO binding capacity of PK11195 
[46] and no novel drugs have been found to label microglia with similar efficacy.  
 
Figure 3.1.4. PET imaging using the microglia selective molecular imaging probe 
PK11195. Adapted from [54]. 
With their phagocytic capabilities and ability to migrate rapidly in response to 
stimuli, microglia are popular candidates as therapeutic vehicles for gene therapy [55, 
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56]. They can be applied for numerous tracking and labelling applications. An 
example of the use of labelled microglia in therapeutic applications is a report by 
Ribot et al. 2011 which describes the use of microglia in human glioma therapy [56]. 
For this purpose, the authors used microglia labelled with contrast agents for in vivo 
tracking in magnetic resonance imaging (MRI).  While it is clear that activated 
microglia contribute to neuroinflammation by potentiating the immune response, 
recent studies also suggest that they play a critical role in neuronal pruning during 
neural development [57]. Defects in this microglia pruning process may contribute to 
autism spectrum disorders and schizophrenia
 
[58]. Microglia have also been shown to 
accumulate efficiently in brain tumours although their role in glioma biology is still 
unclear [42]. Thus there are clearly many diverse and potentially useful applications 
for the use of microglia specific probes in in vitro and in vivo studies. 
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3.2. Microglia specific live cell probes for live cell 
imaging. 
 
Leong C, Lee SC, Ock J, Li X, See P, Park SJ, Ginhoux F, Yun SW, Chang 




CDr10 chemical synthesis was performed by Lee SC. 
Cytokine expression and nitric oxide assays were performed by Ock JY. 
Mass spectrometry studies were performed by L. X. 





Small molecule fluorescent probes have significant advantages over conventional cell 
labelling techniques due to their versatility and ease of use. Unlike antibody or 
fluorescent protein cell labelling methods which require fluorophore conjugation or 
genetic intervention, these dyes are intrinsically fluorescent and cell type specific 
making them ideal tools of generic application. Here we present fluorescent small 
molecule probes, CDr10b and CDr10a that can label live microglia specifically 
without compromising the cell function. The chloroacetyl motif on CDr10b in 
particular is useful for stable binding in live cells over extended durations. The 
fluorescence signal may also be used as a reporter of cell activation status when 
investigating the role of microglia in neural development and neuroinflammatory 
diseases. This will be useful for researchers who are keen to monitor live microglia in 







MATERIALS AND METHODS 
Synthesis and characterization of CDr10b: The aminophenyl bodipy (10 mg, 32 
µmole) and 3-ethoxy-4-methoxybenzaldehyde (8.6 mg, 48 µmole) were dissolved 
with acetonitrile (5 mL) in 20 mL vial and 3 eq. of pyrrolidine and acetic acid were 
added to reaction mixture. The reaction vial was heated to 60 ℃ by heating block 
reactor for 3 hrs. After reaction completion, NaHCO3 saturated solution (50 µL) and 
chloroacetylchloride 20 µL were added to reaction mixture. Crude compound was 
purified by column chromatography and obtained product was 15 mg. 
1
H-NMR (CD3OD + CDCl3) δ 8.36 (s, 1H), 7.71 (m, 3H), 7.55 (d, J = 16.0 Hz, 1H), 
7.39 (d, J = 8.5 Hz, 2H), 7.33 (d, J = 16.0 Hz, 1H), 7.17 (m, 2H), 6.88 (d, J = 9.0 Hz, 
1H), 6.72 (s, 1H), 6.38 (bs, 2H), 4.25 (s, 2H), 4.18 (m, 2H), 3.92 (s, 3H), 1.63 (s, 3H), 
1.50 (t, J = 7 Hz, 3H), 
13
C-NMR (CDCl3) δ 165.35, 158.33, 150.99, 148.28, 145.69, 
140.13, 138.52, 136.95, 134.65, 129.95, 129.49, 128.76, 122.30, 119.42, 119.12, 
115.96, 111.15, 110.86, 64.30, 55.57, 42.66, 29.31, 15.01, 14.22; ESI-MS m/z (M + 
H)
+
 calc’d: 550.18, found 550.20, 530.20 (M - F)+ 
Synthesis and characterization of CDr10a: 
1
H-NMR (CD3OD + CDCl3) δ 8.46 (s, 
1H), 7.76 (m, 3H), 7.65 (d, J = 16.0 Hz, 1H), 7.43 (d, J = 8.5 Hz, 2H), 7.32 (d, J = 
16.0 Hz, 1H), 7.19 (m, 2H), 6.89 (d, J = 9.0 Hz, 1H), 6.75 (s, 1H), 6.39 (bs, 2H), 4.20 
(m, 2H), 3.95 (s, 3H), 2.04 (s, 3H), 1.71 (s, 3H), 1.49 (t, J = 7 Hz, 3H), 
13
C-NMR 
(CDCl3) δ 165.45, 159.33, 151.99, 147.28, 146.69, 140.33, 138.55, 136.98, 134.65, 
129.95, 129.49, 128.76, 123.30, 119.52, 119.82, 114.96, 112.15, 110.86, 64.30, 
55.58, 42.66, 29.51, 15.01, 14.22; ESI-MS m/z (M + H)
+





Synthetic materials & method:  All reactions were performed in oven-dried 
glassware under a positive pressure of nitrogen. Unless otherwise noted, starting 
materials and solvents were purchased from Aldrich and Acros organics and used 
without further purification. Analytical TLC was carried out on Merck 60 F254 silica 
gel plate (0.25 mm layer thickness) and visualization was done with UV light. 
Column chromatography was performed on Merck 60 silica gel (230–400 mesh). 
NMR spectra were recorded on a Bruker Avance 300 MHz NMR spectrometer. 
Chemical shifts are reported as δ in units of parts per million (ppm) and coupling 
constants are reported as a J value in Hertz (Hz). Mass spect ara of all the compounds 
were obtained by LC-MS from Agilent Technologies with an electrospray ionization 
source. The Phenomenex C18 (50 mm × 4.6 mm, 5 µm) column was used for purity 
confirmation with 0.1% TFA containing acetonitrile/water gradient (5% to 100% in 
10 min) elution conditions. Spectroscopic measurements were performed on a 
fluorometer and a UV/Vis instrument, Synergy 4 of Bioteck Company and Gemini 
XS fluorescence plate reader. The slit width was 1 nm for both excitation and 
emission. Relative quantum efficiencies were obtained by comparing the areas under 







where Φst is the reported quantum yield of the standard, I is the integrated emission 
spectrum, A is the absorbance at the excitation wavelength, and  is the refractive 
index of the solvents used. The subscript × denotes unknown and st denotes the 
standard. Rhodamin B was used as a standard and the sample concentration was 10 
µM in DMSO. 




pH response: pH response from pH 2 to 12 was measured using 10 µM of CDr10b, 
CDr10a or pHrodo (Life technologies) in 50% DMSO/50% pH buffer at the known 
excitation and emission wavelengths using a fluorescence plate reader.  
Cell culture: Primary brain cultures were generated from the whole brains of 
postnatal day 1-3 (P1-3) FVB/N mice by trypsinization and trituration methods in 
accordance with the animal handling regulations of our institution. Briefly, fresh 
brains were incubated with 0.25% trypsin for 1 hour at 37°C, followed by 
neutralization with Fetal Bovine Serum (FBS). A single cell suspension was 
generated by sequential trituration using pipette tips of decreasing diameter. Finally, 
the cell suspension was filtered using a 40-micron strainer.  Cells were grown in 
DMEM/F12 (Gibco) with 10% FBS and 1% penicillin-streptomycin (Gibco). BV2 
and MEF cells were cultured in DMEM + 5% FBS and DMEM + 20% FBS 
respectively with 1% penicillin streptomycin (Gibco). 
High throughput screening: Primary neurons and primary astrocyte enriched 
cultures were generated using the adherence isolation protocol by Jana et.al [29]. 
Primary microglia enriched cultures were generated by adherence methods and 
harvested using the mild trypsinization method as described by Saura et.al [30]. Each 
cell type isolated by these methods was 80-90% pure when determined by 
immunocytochemistry. Neuron, astrocyte and microglia enriched cultures were plated 
in duplicate on to 384 well plates and incubated with 500 nM of fluorescent 
compound for 1 hour before image acquisition using the ImageXpress Micro 
TM
 high 
throughput screening system. 
Immunocytochemistry: Primary neural cells were fixed in 4% PFA and 
permeabilized with 0.1% Triton-X (Sigma). Cells were identified using the following 
markers at the respective dilutions: microglia – Iba (Wako) 1:500, astrocytes - GFAP 
(DakoCytomaton) 1:1,000, neurons - β-III-tubulin (Sigma) 1:1,000 and 
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oligodendrocytes (Millipore) 1:500. For secondary antibody staining, anti-mouse 
Alexa Fluor 546 IgG, anti-rabbit Cy5 IgG and anti-mouse Alexa Fluor 488 IgM 
(Invitrogen) 1:1000 were used. Images were scored using intensity analysis software 
MetaXpress® and confirmed by image-based manual analysis for the identification of 
hit compounds.  
Cell staining fluorescence imaging: Cells were stained with 500 nM of CDr10 for 1 
hour followed by 1 hour of washing in fresh media before image acquisition. All 
fluorescence microscopy was carried out using the ECLIPSE Ti microscope (Nikon 
Instruments Inc) on the NIS Elements 3.10 software. For images of organellar 
localization (mitochondria, lysosomes, endoplasmic reticulum and golgi), we used the 
following fluorescent dyes from Life technologies: Mitotracker Green, Lysotracker 
green, ER tracker green and Golgi tracker green. Images were acquired using a LSM 
5 DUO (inverted) Laser Scanning Confocal Microscope. 
siRNA knockdown of MTCO2:  BV2 cells were treated with 50 -100 µM of S1, S3, 
or S5 for 48 hours. They harvested for RNA extraction of stained with 500 nM of 
CDr10 for SDS-PAGE.  
Flow cytometry: Primary brain cell cultures were generated from the brains of P1 
CX3CR1-GFP pups as described above. Cells were stained with 500 nM of 
compound for 1 hour and washed with PBS before acquisition on the BD LSR II 
analyzer. Cells were acquired using the appropriate filters for GFP and Texas Red 
wavelengths. 
Washing and SDS-PAGE: BV2 microglia were stained with 500 nM of CDr10b or 
CDr10a for 1 hour and washed for 1 hour with DMEM + 10% FBS or 100% 
methanol and imaged at the same exposure time as unwashed cells. For SDS-PAGE, 
BV2 microglia were stained with 500 nM of CDr10b or CDr10a for 1 hour followed 
by cell lysis with Cell Lytic M (Sigma). 20 µg of cell lysate was run on 12 % SDS-
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PAGE and analyzed using a typhoon fluorescence scanner. The gel was then stained 
with comassie blue.  
Cytotoxicity assays: Cytoxicity assays were carried out using the MTS reagent kit 
(Promega) on 24h compound treated BV2 microglia cells in accordance with the 
manufacturer's instructions.  
Real time RT-PCR: Total RNA was isolated from the cells using the RNeasy Mini 
Kit (QIAGEN Inc.) according to the manufacturer’s instructions. Gene expression for 
the cytokines IL-6, TNFα and GAPDH was measured using the Power SYBR® 
Green RNA-to-CT™ 1-Step Kit (Applied Biosystem) on a StepOne™ Real-Time 
PCR System (Applied Biosystems). mRNA levels of the above mentioned genes were 
normalized to GAPDH expression levels using the Q-gene relative expression 







Nitric oxide assay: BV2 cells were pretreated for 1 hour with 500 nM of CDr10 
before addition of 100 ng/μl of LPS or 20 U/ml (20 ng/ml) of IFN-γ in fresh media. 
After incubation for 24 hours, 50 μl of cell culture media was mixed with an equal 
volume of Griess reagent (Sigma) in a 96 well plate. Light absorbance was measured 
at 540 nm. Nitric oxide concentration was determined by comparison with a standard 
curve generated from a titration of sodium nitrite. 
Activation intensity measurements by imaging: BV2 cells were activated with 100 
ng/μl of LPS for the stipulated times. One hour before image acquisition 500 nM of 
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CDr10 was added to the cells. Cells were imaged using the ImageXpress high 
throughput system at 20X magnification and intensity measurements were calculated 
by intensity based multi-wavelength scoring.  
Live cell tracking: For cell proliferation tracking, BV2 microglia were stained for 1 
hour with 500 nM of CDr10. This was followed by 1 hour of washing in maintenance 
media. Cell media was replaced once more before video acquisition. For cell tracking, 
videos were acquired on the BioStation IM (Nikon) at 10X magnification for 24 
hours. Similarly, cell tracking was carried out on primary mixed glial cell cultures 
stained for 1 hour with 500 nM of CDr10.  
For imaging cellular interactions, U251 glioma cells were treated with 10 uM of 
camptothecin. After 24 hours, media was replaced and the U251 cells were stained 
with 500 nM of Cell Tracker Green (Invitrogen) for 1 hour.  BV2 microglia were 
stained for 1 hour with 500 nM of CDr10. After staining, both cell types were 
washed briefly in fresh media. Stained BV2 microglia were trypsinized and seeded 
with the U251 cells. Images were acquired over 36 hours on the Biostation IM 
(Nikon) at 20X magnification 
Live cell washing: BV2 microglia were stained with 500 nM of compound for 2 
hours. Cells were then briefly rinsed with fresh media and imaged using the 
Biostation IM (Nikon) at 10X magnification for 20 hours at intervals of 15 mins. For 
the quantification of signal intensity, the Time Series Analyzer plugin (Balaji, J. 
2007) was used. Values were averaged from a set of three regions of interest, each 
consisting of 3-10 cells.  
Methods for target identification 
Protein extraction: The compound stained BV2 cells were lyzed with solution 
including 0.1% TFA, 5% acetonitrile (ACN). The cells were suspended in the 
solution and ultrasonicated for 4 min using 40% power, 6 sec on/ 3 sec off cycle. The 
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lysate was centrifuged for 5 min at maximum speed to remove the insoluble debris. 
The protein concentration of the supernatant was measured by Bradford method. 
Off-line LC separation: Dionex Ultimate 3000 2D LC system was employed to 
fractionate the cell lysate using Dionex  ProSwift RP-2H column. The 40 min HPLC 
gradient consisted of 100% buffer A (0.1% TFA, 5% ACN) for 2 min; 0−24% buffer 
B (0.1% TFA, 95% ACN) for 3 min; 24-62% buffer B for 25 min; 62−100% buffer B 
for 2 min followed by 100% buffer A for 3 min; 100% buffer A for 5 min. In total 40 
fractions were collected. The chromatography was recorded by UV detector at 214nm 
and by fluorescence detector at 610nm. The fractions that carry the fluorescent signal 
were selected to concentrate to dryness using vacuum centrifuge.  
SDS-PAGE gel separation: The fractions collected and dried from the LC separation 
were separate by 4-15% SDS-PAGE gel or 12% SDS-PAGE gel. The gel was 
scanned by Typhoon 9400 variable mode imager (Amersham Biosciences, NJ). The 
gel band carrying fluorescent signal was cut out for in-gel digestion. 
In-gel digestion: The proteins that trapped in the gel pieces was reduced by 
dithiothreitol (DTT) and alkylated by iodoacetamide (IAA). Tryptic digestion was 
performed by using porcine trypsin (Sequencing Grade Modified, Promega, 
Wisconsin) overnight. The tryptic peptides were extracted by 5% formic acid in 50% 
ACN and vacuum dried by vacuum centrifuge. 
Data analysis: The peak list was submitted to Mascot server for searching against the 
uniprot_sprot database. The Mascot dat file was processed by in-house program to 
select those peptides with score above 20 and peptides with score above identity 
score. The peptide number for each protein was calculated. Proteins were grouped 





CDr10 shows specificity for microglia 
We identified a fluorescent probe specific for microglia from a BODIPY structure 
library. This dye exhibited good cell permeability, high photostability, low toxicity 
and high fluorescence response when bound to target. The compound was named 
Compound of Designation red 10 binding (CDr10b, ex/em = 571 nm/611 nm) 
(Figure 3.2.1; see Appendix 8.1.2 for chemical synthesis and characterization). The 
specificity of CDr10b to microglia was confirmed in the microglia cell line BV2 by 
the identification of brightly labelled BV2 cells when co-cultured with mouse 







Figure 3.2.1. (a) The excitation emission spectra of CDr10b (b) Structure of CDr10b 
(c) BV2 cells co-cultured on mouse embryonic fibroblasts and stained with 500 nM 
of CDr10b. Scale bar; 50 µm (d) Mixed primary neural cells derived CX3CR1-GFP 
mice were stained with 500 nM of CDr10b and imaged or analyzed by flow 
cytometry (e) Scale bar; 10 µm. 
To further validate the specific staining of CDr10b in microglia, we employed the 





Heterogenous cultures of mixed primary brain cells derived from postnatal day 1-3 
CX3CR1-GFP mouse pups were incubated with CDr10b and analyzed by 
fluorescence microscopy and flow cytometry. CDr10b shows robust staining that 
labels microglia populations in heterogeneous cultures at a level that is comparable to 
fluorescent protein expression techniques (Figure 3.2.1d). This is also seen by the 
near homogenous shift of the GFP-positive microglia population (11.8% of brain 
cells) from the GFP only region to the Texas Red and GFP region on addition of 
CDr10b (Figure 3.2.1e). Ionized calcium-binding adaptor molecule 1 (Iba1) and 
isolectin B4 are well known microglia markers [59].  Microglial cell identity of 
CDr10b-stained cells was verified by immunostaining of Iba antibody and isolectin 
B4 binding (Figure 3.2.2).  
 
     
Figure 3.2.2. Co-labeling of microglia with other markers.  (a) Primary microglia 






stained with 500 nM of CDr10b and imaged using a Texas red filter. CDr10b shows 
specificity for primary microglia and does not stain other primary neural cells. To 
confirm for cell type, the cells were fixed and immunostained for the microglia cell 
surface marker, Iba (green) and the corresponding neuron (β-III-tubulin - yellow), 
astrocyte (GFAP - red) and oligodendrocyte (O4 -green) markers. Scale bar; 50 µm. 
(b) Isolectin B4 (Green) staining of BV2 microglia co-cultured with U251 glioma 
cells with CDr10b and CD10a (red). Scale bar; 20 µm. 
The chloro-acetyl motif is important for stable binding  
The chloro-acetyl motif of CDr10b is hypothesized to be a key binding region due to 
its capacity to form covalent bands with thiols [60, 61].  To determine the structure 
activity relationships (SARs), a derivative of CDr10 acetyl (CDr10a, ex/em = 570 




, quantum yield = 0.1) was 
synthesized that did not contain a chloro-acetyl motif – (Figure 3.2.3a). CDr10a was 
shown to have similar specificity for microglia in cultures of mixed fibroblasts and 
BV2 microglia (Figure 3.2.3b).  
 
 
Figure 3.2.3. Microglia specificity of CDr10a. Primary neural cells from CX3CR1-
GFP mice were stained with 500 nM of CDr10a and imaged by fluorescence 




primary neural cells derived CX3CR1-GFP mice were stained with 500 nM of 
CDr10a and imaged or analyzed by flow cytometry (d) Scale bar; 10 µm. 
Absence of the chloro-acetyl motif in CDr10a was primarily manifested in decreased 
strength of binding. Washing of the stained cells with media or organic solvent 
resulted in a significant loss in CDr10a staining whereas CDr10b dye signal was 
resistant to the above mentioned treatments (Figure 3.2.4a), with up to 90% of signal 
retained in the cells even for 19 hours after the compound was removed from cell 
culture media (Figure 3.2.4b). This suggests that CDr10b binding is covalent. When 
stained cell lysates were run on SDS-PAGE, CDr10b binding survived gel running 
conditions, while CDr10a binding did not as seen from the absence of fluorescently 
labeled protein bands (Figure 3.2.5). Thus it is likely that while the removal of the 
chloro-acetyl motif does not affect specific binding to the target, it abolishes the 
ability of the dye to bind covalently to its target protein and survive washing and 
downstream processing. Both compounds showed negligible changes in fluorescence 
response when compared alongside a known fluorescence sensor, pHrodo in 













Figure 3.2.4. (a) CDr10b cell staining was relatively resistant to washing with 
methanol and media whereas CDr10a staining was completely washed out. Scale bar; 
50 µm. (b) Time-course analysis of CD10b and CDr10a destaining. A percentage 
average intensity plot of CDr10b and CDr10a stained cells over 19 hours in media 
without compounds. CDr10a signal is rapidly washed out but CDr10b signal 
remains relatively constant. (c) pH response of CDr10b and CDr10a. CDr10b (red) 
and CDr10a (blue) did not show any pH response compared to pHrodo, a known acid 
responsive fluorescent dye.  
 
Cytochrome c oxidase subunit 2 as a binding target 
For the identification of the binding target, BV2 microglia were stained with CDr10b 
and the whole cell lysate run on HPLC. The compound positive protein peak was 
fractionated and collected for SDS-PAGE (Figure 3.2.5). Following silver staining 
and mass analysis, a list of candidate proteins were identified based on the peptide 
sequence (Table 3.1). The protein, cytochrome c oxidase subunit 2 was identified as 















Figure 3.2.5. SDS-PAGE of CDr10a- and CDr10b-stained microglia cell lysates. 
(a) 1D SDS-PAGE - CDr10b-stained BV2 cell lysate shows prominent dye labeled 
bands. No signal was detected from control and CDr10a-stained cell lysate. (b) 
HPLC detection and fractionation- The major fluorescence peak from HPLC of 
CDr10b-stained BV2 cell lysate was fractionated and run on 1D SDS-PAGE. (c) 
Silver staining confirmed that it corresponded with the major fluorescent band 
identified from (a). *Data courtesy of Dr. Li Xin. 
In the experiment using 12% SDS-PAGE gel as secondary separation, 11 peptides 
above identity score were identified. 4 peptides can be assigned to COX2_MOUSE, 5 
peptides can be assigned to RTN3_MOUSE, 1 peptide can be assigned to 
RB11A_MOUSE or RB11B_MOUSE and 1 peptide can be assigned to 
RL15_MOUSE (Table 3.1). 
 
 










Lane 1: Unstained cells 
Lane 2: CDr10b stained 
cells 
Lane 3: CDr10a stained 
cells 














COX2_MOUSE, 33.28 31.28 25kDa TDAIPGR 
COX2_MOUSE, 34.88 33.08  TDAIPGR 
COX2_MOUSE, 47.60 38.54  VVLPMELPIR 
COX2_MOUSE, 35.65 32.32  VVLPMELPIR 
RB11A/B_MOUSE, 22.65 22.49 24kDa/ 
14kDa 
AQIWDTAGQER 
RL15_MOUSE, 36.59 36.39 15kDa SLQSVAEER 
RTN3_MOUSE, 54.67 31.09 113kDa AESSAATQSPSVSSSSSGAEPSALGGGGGSPGACPALGAK 
RTN3_MOUSE, 39.81 28.80  AESSAATQSPSVSSSSSGAEPSALGGGGGSPGACPALGAK 
RTN3_MOUSE, 35.44 27.28  AESSAATQSPSVSSSSSGAEPSALGGGGGSPGACPALGAK 
RTN3_MOUSE, 44.64 27.98  AESSAATQSPSVSSSSSGAEPSALGGGGGSPGACPALGAK 
RTN3_MOUSE, 46.61 29.66  AESSAATQSPSVSSSSSGAEPSALGGGGGSPGACPALGAK 
*Data courtesy of Dr. Li Xin 
COX2_MOUSE (Uniprot ID: P00405, Full name: Cytochrome c oxidase subunit 2) 
was identified as the primary binding target based on its molecular weight and 
identity score.  Cytochrome c oxidase is a component of the oxidative 
phosphorylation chain and constitutes one of the four enzyme subunits in the 
cytochrome c oxidase complex. It contains the substrate binding site of the enzyme 
and is responsible for transferring electrons from cytochrome c to catalytic subunit 1 
[62]. The protein is known to be localized to the mitochondrial inter membrane space 
and  gene expression analysis done on microglia cells sorted by the CD11b antibody 
marker indicate that cytochrome c oxidase subunit 2  is indeed up to 2 fold over 
expressed in CD11b positive cells (microglia) (Figure 3.2.6). Gene expression 
analysis for F4/80 and β-III-tubulin were included as positive and negative sorting 




Figure 3.2.6. Cytochrome c oxidase subunit 2 expression in CD11b sorted cells. The 
expression of F4/80 and β-III-tubulin were used as positive and negatively sorting 
controls respectively.  
Attempts to quantify cytochrome c oxidase subunit 2 protein expression from extracts 
of BV2 cell lysate were unsuccessful because there appear to be no antibodies 
currently available on the market which are capable of recognizing mouse 
cytochrome c oxidase subunit 2 specifically. We attempted to validate dye target 
binding by employing siRNA knockdown of the cytochrome c oxidase subunit 2 
protein. We tested 3 siRNA sequences- S1, S3 and S5 (Figure 3.2.7a). 24 hours 
incubation with a combination of the siRNA sequences S3 and S5 successfully 
knocked down gene expression of the protein by up to 50%. However, this failed to 
give any decrease in the strength of the band signal. Given that cytochrome c oxidase 
is a critical enzyme in metabolic energy generation, it is very likely that a complete 
protein knockdown of key catalytic subunits like MTCO2 is protected by 





siRNA Design Start Target Sequence 
SC1 sc AUACUUACGC AUAUUAUUC  ATACTTACGCATATTATTC 
S1 s CUGUAAUCCUUAUCAUAAUdTdT 209 CTGTAATCCTTATCATAAT 
S1 a AUUAUGAUAAGGAUUACAGdTdT 209 ATTATGATAAGGATTACAG 
S3 s CAAUCCGUAUAUUAAUUUCdTdT 446 CAATCCGTATATTAATTTC 
S3 a GAAAUUAAUAUACGGAUUGdTdT 446 GAAATTAATATACGGATTG 
S5 s GCUAGAAGUUGAUAACCGAdTdT 405 GCTAGAAGTTGATAACCGA 









Figure 3.2.7. (a) SiRNA sequences for targeted regions of MTCO2 expression. SC1 
was used as a scrambled control sequence. (b) Only sequences S3 and S5 reduced 
MTCO2 gene expression by 50%.  (c) Fluorescence intensity of CDr10b was 
normalized to protein amount from comassie blue staining but no differences in 
fluorescence intensity were observed upon siRNA treatment with sequences S3 and 
S5.  
CDr10b and CDr10a do not affect cell viability and functionality 
The aim of live cell labelling is to achieve robust labelling without cytotoxicity or 
interference with normal cellular response. This is critical for microglia, which are 
the key immune cells of the brain responsible for pathogen invasion. To assess 
cytotoxicity, we stained the cells for 24 hours with up to 0-10 µM of CDr10b and 
measured cell viability using an MTS assay. At all concentration ranges of CDr10b, 
cells showed no decrease in viability compared to controls (Figure 3.3.7). This was 
validated by time course imaging of CDr10b stained BV2 cells (Supplementary 
Video 3.2.1), which shows stained BV2 cells moving and dividing actively over a 













































































Figure 3.2.8.  (a) MTS assay of 24 hour CDr10b and CDr10a stained BV2 microglia 
cells. (b) The effect of CDr10b (500 nM) on cell proliferation was analyzed by cell 
counting of live and dead cells using SYTOX Green and Hoechst 33342 nuclei 
staining (Invitrogen) at 0, 24 and 48 hours. The number of live cells was calculated 
by subtracting dead cells (SYTOX Green positive cells) from all cells (Hoechst 
staining). 
 In response to activation by LPS challenge, mRNA levels of TNF-α and IL-6 and 
production of nitric oxide in CDr10b-stained BV2 cells increased 4, 1.5 and 6 folds 
respectively. These responses were comparable with those of non-compound treated 
cells (Figure 3.3.8a). To examine whether the compound itself has any intrinsically 
activatory effects on microglia, BV2 cells were treated with 0.5-5 µM of CDr10b. 
Measurement of nitric oxide release showed no sign of activation at whole 







Figure 3.2.9. Microglia functional assay. (a, b) BV2 cells were pretreated for 1 
hour with 500 nM of CDr10 before addition of 100 ng/ml of LPS in fresh media. 
After 6 hours, total RNA was isolated from the cells and mRNA expression levels of 
IL-6 (a) and TNF-_ (b) were measured by RT-PCR. All values were normalized to 
GAPDH expression levels. (c) For the measurement of nitric oxide concentration, 
cells were pretreated with 500 nM of CDr10 before addition of 100 ng/ml LPS. After 
incubation for 24 hours, nitric oxide production was measured using the Griess assay 
and concentrations determined by comparison to a standard curve. (d) BV2 cells were 
pre-treated for 1 hour with CDr10 (0.5-5 μM), followed by the addition of LPS 24 
hours before nitric oxide measurement. BV2 cells treated with LPS for 24 hours were 
used as a positive control. *Data is courtesy of Dr. Ock Jiyeon 
Co-labelling with organellar trackers 
Confocal microscopy of the BV2 microglia cell line showed that the compound is 
localized mainly to the cytoplasm of the cell, excluding the nucleus and plasma 
membrane.  Co-staining with organelle trackers showed that CDr10b does not  co-
localize in entirety with mitochondria, endoplasmic reticulum, golgi or lysosome 






Figure 3.2.10. CDr10b labeling with organelle trackers. BV2 microglia were co-
stained with their respective organelle trackers and CDr10b to determine the level of 
co-localization. Scale bar; 5 µm.  
 
Activated microglia show brighter CDr10 fluorescence 
In addition to labelling microglia, we were interested to see if CDr10b could also 
serve as a reporter of cell activation status by discriminating resting and activated 
microglia by measurement of fluorescence intensity. To investigate this, BV2 cells 
activated by LPS were stained with CDr10b and analyzed in parallel with non-
activated cells. Both microscope image and flow cytometry data showed that 
activated microglia are up to 2 times brighter than their non-activated counterparts 
(Figure 3.2.11). This was validated by time lapse imaging of activated CDr10b-
stained BV2 cells which showed that faster and more actively moving i.e. hence more 




Gene analysis of the identified protein target expression showed that compared to 
non-activated cells, LPS and IFN-γ activated microglia show a slightly increased 
expression of MTCO2 (Figure 3.2.11c). However, these changes were small and may 
not reflect the full increase at protein level which may be amplified by other 








Figure 3.2.11. BV2 microglia activated with LPS show brighter CDr10b staining 
intensity as compared to their non-activated counterparts (a) Flow cytometry 
histogram (b) Fluorescence microscopy images. Scale bar; 50 µm. (c) Gene 
expression of MTCO2 in LPS and IFN-γ activated cells. The gray scale bar on the 
right shows the amplified bar graph highlighting the subtle increase in MTCO2 









Application in live cell imaging and sorting 
CDr10b for live cell imaging  
Microglia are dynamic cells that carry out a host of cellular activities such as 
‘searching’ (resting microglia), migration towards an inflammatory stimulus and the 
phagocytosis of unwanted cellular materials such as dead and dying cells [51]. To 
demonstrate this, mixed primary brain cell cultures were stained with CDr10b and 
observed over 36 hours. Time course imaging showed defined, labelled cells 
‘searching’ in a mixture of primary brain cells (Supplementary Video 3.2.3).  
Microglia play an active role in phagocytosis, especially in the presence of dead and 
dying cells. This process is dependent on the presentation of extracellular 
phosphotidylserine which is induced by the application of apoptotic drugs such as 
campthothecin or etoposide [63].  As a demonstration of probe utility in a dynamic 
setting, we placed the microglia cells in co-culture with camptothecin treated U251 
human glioma cells labelled with Cell Tracker Green (Invitrogen) and mixed primary 
brain cells. Cell labelling with CDr10b was sufficiently robust to observe distinct 
signals from individual cells, and CDr10b-labeled microglia cells were seen 
attacking and engulfing green fluorescent glioma cells over extended duration time 









Figure 3.2.12. Video stills from cell imaging videos show CDr10b positive (red) 
BV2 cells and Cell tracker green labelled glioma cells (green) undergoing 
phagocytosis. Two green labelled glioma cells (yellow & white arrows) undergo 
attack by red labelled microglia. The white arrow labelled microglia is eventually 
completely phagocytosed. Scale bar; 10 µm. 
CDr10a for live cell sorting 
The weak binding affinity of CDr10a makes it best suited to conditions whereby 
transient binding is desired. An example would be for the isolation of microglia from 
preparations of mixed primary neural cells by Fluorescence activated cell sorting 
(FACs). Sorting for CDr10a enriched for the population of CD11b positive cells 
(microglia) by up to 5 fold and the transient binding of CDr10a enables the cells to 
be relabelled with probes of a similar colour for other downstream purposes (Figure 
3.2.13).  
 
Figure 3.2.13. Cells sorted from CDr10a Bright (10%) and Dim (10%) cells were 
immunolabelled with CD11b antibody and measured for microglia enrichment.  
 
CDr10b: Compound specificity within the CNS and myeloid lineage systems  
A subject of continual controversy in the field of microglia research is how to 
discriminate between native microglia present from embryogenesis and myeloid 
precursors that migrate into the brain later in adult life and differentiate into 
microglia/macrophages. Because both types of cells derive from a similar lineage, 
they share many similar markers thus making it difficult to differentiate the two [49]. 
However it has been found that the origins of these phagocytic cells matter, especially 




microglia, but myeloid precursors that migrate into the damaged areas of the CNS 
which are accountable for neuroinflammatory damage during disease [48].  Small 
molecule fluorescent probes have been developed for the NIR imaging of 
macrophages in inflammation [65]. However, their ability to label microglia in the 
brain has not been tested. Thus the identification of markers to discriminate the two 
types of microglia/macrophages has been of considerable interest since it would 
enable us to develop targeted therapeutics for neuroinflammation.  
We attempted to determine if CDr10b was able to specifically label microglia in vivo 
by intravenous injection. Although pharmacokinetics studies did indicate that the 
compound is able to bypass the BBB to enter the cells of the brain (Appendix 8.3), 
we were unable to detect specifically labelled microglia cells from cryosectioned 
fresh frozen brain samples from mice intravenously injected with CDr10b. This 
suggests that the dye may not be available in sufficient amounts to be detected in the 
brain. However, analysis of the white blood cells of mice injected with CDr10b did 
suggest that the dye is also specifically labelling, monocytes - a member of the 
myeloid family from which microglia are derived.  
Studies of CDr10b on white blood cells isolated from mouse blood indicate that they 
are  selective for a distinct CD11b positive population (Figure 3.2.14). Secondary 
gating on the CDr10b+CD11b+ positive population identifies them as a 
predominantly monocyte and granulocyte population based on their scatter profile. 
This suggests that that the specificity of this dye is likely to be lineage specific. Based 
on this, we were interested to see if we could identify compounds from our library 




Figure 3.2.14. White blood cells from mouse blood were co-stained with CDr10b 
and CD11b (Left). The scatter profile from secondary gating on the 
CDr10b+CD11b+ positive population (Right).  
A screen was carried with the 6 original microglia cell hits and other compounds 
from our DOFL library. Based on image based screening, a total of 4 candidate 
compounds (MKAC C2, BDRAC E2, Taming C8 and BDNCA2 C5) were selected 
for their selectivity to BV2 microglia over RAW macrophages. This was further 
narrowed down to 2 final hits (Taming C8 and BDNCA2 C5) based on a screening of 
BV2 cells and primary cell derived peritoneal macrophages, monocytes and bone 
marrow derived macrophages (Figure 3.2.15). 
 




Despite attempts to optimize staining conditions for the cells, it was difficult to 
eliminate background staining from bone marrow derived macrophages completely 
when compared alongside primary microglia cells. Interestingly, peritoneal 
macrophages and white blood cells showed little or no staining compared with 
primary microglia and bone marrow derived macrophages. The strong correlation 
between the staining intensity of primary microglia and bone marrow derived 
macrophages once again emphasizes that both types of cells are very closely linked in 
lineage and that the dye is likely to be binding to a target that is relatively strongly 
expressed in both cells (Figure 3.2.16). Thus it is likely that both cells are 
phenotypically similar and diverge primarily in function.. In which case, the use of 
functional markers such as cytokine expression profiles and response to stimulus 



















Figure 3.2.16. (a) Images from screening of the candidate compounds on BV2 
microglia and RAW macrophages as well as primary derived myeloid cells. Scale 
bar; 20 µm. (b). Representative cell panel images of primary cell derived microglia 
and macrophages stained with Taming C8 and BDNCA2 C5. 
 
DISCUSSION 
CDr10b and CDr10a have been identified as microglia specific small molecule dyes 
which are effective in labelling cells in vitro quickly and effectively. It also offers a 
significant advantage over conventional antibody labelling techniques because it 
enables real time staining and observation of the labelled cells with minimal effect on 
native cellular function. In the above, we have demonstrated that CDr10 may also be 
used in combination with other fluorescent molecules for the elucidation of dynamic 
cellular cues and interactions such as that demonstrated by the phagocytosis of 




Target identification by mass spectrometry analysis of the fluorescent protein spot 
identified the target binding protein to be cytochrome c oxidase subunit 2, a key 
component of the oxidative phosphorylation pathway that is localized in the 
mitochondrial membrane. This was validated by gene expression studies which show 
that cytochrome c oxidase is more highly expressed in microglia. Unfortunately we 
were unable to further validate the specificity of this target binding due to the 
unavailability of antibodies with suitable reactivity and the apparent redundancy of 
this protein’s expression which manifests in its strong expression even with siRNA 
knockdown. Given the critical role of cytochrome c oxidase subunit 2 in oxidative 
phosphorylation, it is likely that further attempts to knockdown or modify its protein 
expression will be difficult because it is tightly regulated.  
However, the susceptibility of CDr10a to washing despite its apparent specificity 
suggests that the chloro-acetyl motif of CDr10b is not directly involved in the 
microglia specificity of the probe. Considering this and the broad distribution of the 
probes in the cytoplasm it appears that cytochrome c oxidase subunit 2 expression in 
microglia alone is unlikely to account entirely for the dye selectivity and there may be 
other microglia selective target proteins contributing to dye specificity. .   
CDr10 is unique because it constitutes a novel microglia specific probe in vitro. All 
known microglia probes thus far have been based on the structure of the molecular 
imaging probe, PK11195 which binds to the peripheral benzodiazepine receptor and 
is used to detect activated microglia in the brain. Interestingly, it is also localized to 
the mitochondrial membrane and the ability of both probes to serve as indicators of 
microglia activation status is likely to be associated with increased metabolic demand 
when the cells are activated. The ability to quantify activation status of microglia 
could prove to be a potentially useful inflammation marker in models of 
inflammatory disease for diagnostic and therapeutic applications. A key improvement 
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to these studies would be to carry out more comprehensive SARs studies to improve 
the bioavailability of CDr10 and its ability to bypass the BBB, thus making it 
applicable for in vivo studies. At the moment, only changes to the chloro-acetyl motif 
have been explored. This suggests that it is likely that the other side groups are 
responsible for microglial specificity and that the position of the chloro-acetyl motif 
is tunable for further modifications which may improve compatibility for in vivo 
studies.  
Beyond its specificity for microglia in the brain, CDr10 and the two other microglia-
macrophage hits, Taming C8 and BDNCA2 C5 may also be applicable for the study 
of cells of the myeloid lineage. More specifically, Taming C8 and BDNCA2 C5 
appear to be selective for brain microglia and bone marrow derived macrophages 
which appear to be most closely linked by lineage. However in the scenario whereby 
there is a need to discriminate between native microglia and infiltrating bone marrow 
derived macrophages, it is likely that it will still be necessary to include other external 
antibody markers such as CCR2, Ly6G etc. The prevalence of myeloid cells derived 
cells in the blood and outside the CNS suggests that it is possible to develop our 










CDr10a and b are the first small molecule fluorescent probes identified for their 
intrinsic specificity to microglia. They label microglia quickly and effectively, 
offering significant advantages over conventional antibody labeling techniques 
enabling real time staining and observation of the labeled cells with minimal effect on 
native cellular function. The chloro-acetyl motif on CDr10b has been identified as a 
critical motif for binding stability whereas its lack thereof, as represented by CDr10a 
may make it more suited to applications requiring transient binding. The dyes may 
also be used in combination with other fluorescent molecules for the elucidation of 
dynamic cellular cues and interactions such as that demonstrated by the phagocytosis 
of apoptotic glioma cells. The ability to quantify activation status of microglia could 
prove to be a potentially useful inflammation marker in models of inflammatory 
disease for diagnostic and therapeutic applications. This opens up a wide field of 
applications for which our probes can be applied for the tracking and study of 
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4.1 Introduction to neurons 
Neurons constitute the primary functional cells of the brain and their connectivity and 
electrical activity are critical for human thought and motor function. Elucidating the 
complex neuronal networks that govern neural function have long been a subject of 
interest to neuroscientists who believed that human thought could be deciphered by 
mapping the tangle of neuron connections within the brain [66]. However the 
mechanisms underlying their form and function are still poorly understood and 
considerable efforts are being made to delineate how neurons differentiate, develop 
dendrites synapses and interact with other cells of the brain. 
Neuron morphology and classification 
Neurons can be broadly classified by a variety of different traits. They may be 
identified by the type of neurotransmitter they produce (e.g. GABA, glutamate, 
dopamine, serotonin), their morphology, electrophysiological firing pattern or 
localization in the brain [67]. The characteristic neuron morphology may be described 
as a defined cell body with one or more extended processes emanating from the cell 
[68]. These processes then go on to form branches that eventually constitute the 
complex neural networks of the brain. Examples of neuron morphologies that have 
been well characterized include some of the following: the purkinje cell (Figure 
4.4.1a), which is known for its distinctive tree like branching and the pyramidal cell 
(Figure 4.4.1b), which is characterized by its projection to the cerebral cortex [69]. 
The sheer level of detail required to delineate these cellular connections have 
spawned numerous neuron segmentation techniques which have been engineered to 
digitally reconstruct the neuronal cell, thus providing us with an unlimited resource 




Figure 4.4.1. Digital reconstructions of a purkinje neuron and a pyramidal neuron 
respectively. Images adapted from [69]. 
 
Neuron electrophysiology 
Neurons are unique for their ability to respond to and convey information via 
electrical signalling. This can be attributed to their ability to maintain a resting 
membrane potential (-40 to -90 mV) due to the presence of selective ion channels on 
the neuron cell membrane which maintain an ion differential between the extra and 
intracellular space [68]. A sufficiently large depolarizing stimulus that reaches a 
threshold generates an action potential in neurons, which is the primary means of 
information transmission in the brain.  
The role of calcium ions in the electrophysiology of the neuron has been extensively 
explored by calcium imaging. This utilizes small molecule fluorophores hybridized 
with highly calcium selective chelators such as EGTA or BAGTA [70]. These dyes 
are usually loaded manually onto the cells of interest and include Fura 2, Fura 4 and 
Oregon Green BAGTA and they have become popularly used due to their high signal 
to noise ratio. The changes in the concentration of calcium as reflected by these dyes 
are indicative of functional changes within the cells and may be used to elucidate 






Neurons for culture and isolation 
The absence of good neuronal markers for live cell isolation is a challenge for 
researchers targeting neuronal study [71]. Most primary neuron sorting methods rely 
on sorting neuronal progenitors using the extracellular marker, NCAM [72] or by 
density centrifugation [73], followed by protocols for terminal differentiation. 
Neurons are difficult to culture in large numbers because they cannot be sub-cultured 
and thus require fresh isolation from animal brains for each study. Several cell lines 
e.g. PC12, SY5Y have been shown to exhibit neuronal properties. However these 
neurons may not recapitulate the heterogeneity of native neuronal systems. Adult 
neurons can be isolated for in vitro culture given the appropriate culture and isolation 
conditions [74].  
In the absence of viable primary neurons sources (e.g. human adult or fetal brain 
tissue), neurons are often differentiated from embryonic or neural stem cell lines [75]. 
This enables cultures to be expanded up for larger scale studies which may be 
difficult to achieve with primary tissue harvest.  
Neuron labelling methods 
Given the complex nature of these cells, numerous neuron labelling methods have 
also evolved to visualize them. These include the Golgi method, Nissl staining as well 
as calcium dyes such as Fura and Dil (Figure 4.1.2) [76]. These methods have 
generated beautiful images of neuron architecture, with intricate branching 
morphologies and diverse structures. However, most established neuron labelling 
dyes work best on fixed tissue preparations or are not selective for neurons but rather 
depend on retrograde labelling or manual injection to achieve the desired effect in 




                        
 
Figure 4.1.2. Commercially available neuronal staining methods 
 
A wide range of mouse models expressing fluorescent proteins in the neurons of the 
mouse model are available, the most well known being Brainbow, which employs a 
methodology that involves the use of Cre/lox recombination to express several 
fluorescent proteins under a single promoter, producing stunning images of 
multicoloured fluorescent protein expressing neurons (Figure 4.1.3) [78]. Thus far the 
extensive use of transgenic animal models expressing fluorescent proteins in neurons 
seems to suggest that the fluorescent protein expression does not affect native 
neuronal development and function. However, the expression of fluorescent proteins 
may not be consistent throughout animal development e.g. time needed for activation 
of cre-recombinase in the Thy1 transgenic mouse line[79].  Thus there are windows 
of neuronal development which are still difficult to study with each possibly requiring 
different neuron models for the best fluorescent protein expression. The use of 
lentiviral transfection has also become a popular method for selectively labelling  
neuronal populations of interest [80]. However, these methods are time consuming 
and often suffer from low labelling efficiency. They are also not neuron selective. 
Several groups have developed neuron staining fluorescent dyes based on the 
structures of specific neurotransmitters such as acetylcholine and dopamine[17, 18]. 
However, these methods are limited to the study of the neuron subtype of interest and 
there is yet to be a generic neuron dye available. Apart from the above mentioned, 
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there are no chemical dyes to date that are capable of specifically labelling live 
neurons in their in vitro or in vivo settings. 
The availability of a neuron compound negates the need for antibody and transgenic 
animal use. This is especially useful in the case of neurons because most neuronal 
markers are intracellular (e.g. β-III-tubulin, MAP2. NeuN) and require cell 
permeabilization (and hence cell death). Thus a dye that could label live neurons 
would enable a wide range of cell tracking and isolation applications without the 
restrictions imposed by some of the previously mentioned methodologies 
                     
 
Figure 4.1.3 Fluorescent protein labelling of neurons in transgenic mice 
 
Neurons of the peripheral nervous system 
The nervous system of most vertebrates can be segregated into the Central Nervous 
System (CNS), which comprises the brain and spinal cord and the Peripheral Nervous 
System (PNS) which comprise the remaining nerves/neurons that radiate out from the 
spinal cord to specific regions in the body. While most PNS neurons share similar 
markers to neurons of the CNS (e.g. β-III-tubulin), markers such as peripherin are 
known to be specific to peripheral neurons [81]. Like brain neurons, peripheral nerves 
are important for sensory and motor function, making them prime candidates for 
reconstruction and repair in the event of injury. During surgery, accidental 
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transsection is a practical concern. This is especially so for very fine nerves 
innervating muscle and tissue.  
To circumvent this, efforts have been made to develop nerve labelling methods that 
will allow the visualization of nerves during surgery to avoid such surgical mishaps. 
One practical approach by Whitney et al. was to develop a peptide-fluorophore 
conjugate with specificity towards peripheral nerves [82]. However a limitation of 
this approach is that labelling is restricted to peripheral neurons and cannot penetrate 
the BBB to the neurons of the brain due to the larger size of the peptide-fluorophore 
conjugate. With improvements in cellular labelling and detection techniques, it is 
likely that more novel technologies developed for this purpose will emerge.  
Neurons in disease 
Due to its indispensible role in the brain, any defects in neuron development or cell 
maintenance is likely to manifest in disease. For example, abnormal synaptic pruning 
of neurons during development has been implicated in the pathogenesis of diseases 
such as schizophrenia [83]. In Rett syndrome, which is characterized by mental 
retardation, studies have shown that neurons in these conditions show reduced 
dendritic branching [84]. Even more prevalent are the neurodegenerative diseases 
such as Alzheimer’s (AD), Parkinson’s and Multiple sclerosis, which have begun to 
take centre stage as the developed world comes to terms with aging populations.  
Despite extensive research, the mechanisms underlying their pathology are still 
poorly understood. They are characterized primarily by the degeneration of neurons 
in the CNS and PNS which lead to symptoms such as memory loss and motor 
dysfunction. Some neuroinflammatory factors and cytotoxic molecules such as the 
Tau and Aβ aggregates are also implicated in disease pathogenesis but the extent to 
which they contribute to neuronal degeneration itself is controversial.  
There are presently no methods to detect early stage neuronal degeneration and 
diagnostic imaging or biomarker methods are usually only effective for detection at 
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later stages of the disease, by then which treatment options are limited. Examples of 
current molecular imaging probes in clinical use for amyloid beta plaque detection 
are the Pittburgh compound (PiB) and fluorodeoxyglucose [85] (Figure 4.1.4).  
While these diagnostic methods have thus far appeared promising, researchers have 
been advised to proceed with caution because the presence of -amyloid, while useful 
may not equate directly with clinical AD and its disease progression [85]. With this in 
mind, several research groups have undertaken the task of identifying other Tau or 
A diagnostic probes, which when used in combination with PiB may give a better 
picture of disease progression.  
 
Figure 4.1.4. Top panel, the MRI and PIB PET scans from a person who is 
cognitively normal (left) and from a person with dementia due to Alzheimer's disease 
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ABSTRACT 
Neurons are the principle cells in the brain responsible for neural function. 
Elucidating the complex neuronal networks governing neural function is central in 
understanding human thought [87]. Traditional live neuron labelling methods are 
limited to manual dye loading or transgenic fluorescent protein expression in living 
cells or brain tissue [88]. However, these methods may require extensive manual or 
genetic manipulation resulting in physiological changes that do not reflect the native 
state. As such it is desirable for the development of neuron specific labelling tools 
that are sensitive, safe and easy to use. Here we present NeuO, a neuron-specific 
fluorescent live cell imaging dye screened from our DOFL that can be applied in vitro 
or on brain tissue for real time imaging of neurons. NeuO stains neurons specifically 
in cultures of mixed brain cells of mouse, rat and human origin and can be used for 
live cell monitoring or isolation for downstream culture and analysis. Injected 
intravenously, the dye may also be used to label neurons in the whole mouse brain. 
This is the first demonstration of a small molecule fluorescent dye that has neuronal 
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targeting properties in vitro and in vivo. Its simplicity and versatility sets the stage for 
a host of neuronal targeting applications in cellular and molecular imaging. 
MATERIALS AND METHODS 
Mouse cell culture: Primary mouse brain cultures were generated from the whole 
brains of postnatal day 1-3 (P1-3) C57/BL6 mice by trypsinization and trituration 
methods. All animal work was carried out in accordance with the rules of our 
Institutional Animal Care and Use Committee (IACUC) under the approved IACUCs 
#100564 and #100575 in compliance with the National Advisory Committee For 
Laboratory Animal Research (NACLAR) Guidelines. Briefly, fresh brains were 
incubated with 0.25% trypsin for 1 hour at 37°C, followed by neutralization with 
Fetal Bovine Serum (FBS). A single cell suspension was generated by sequential 
trituration using pipette tips of decreasing diameter. Finally, the cell suspension was 
filtered using a 40-micron strainer. Primary mouse neurons were cultured in 
Neurobasal media supplemented with B27, bFGF (10 μg/μl) on poly-D-lysine coated 
dishes. Neuron enriched cultures of mixed primary mouse neural cells were 
differentiated from neurospheres in DMEM/F12 (GIBCO) supplemented with B27 
and BDNF (50ng/µl) (GIBCO) on poly-D-lysine coated dishes.  
Human cell culture - Neural differentiation of H9 ES cells: Human ES cell line H9 
was maintained in mTeSR1 media on matrigel coated plates and routinely split into 
1:6 ratios. ES cells were differentiated into neural stem cells (NSC) using a protocol 
based on inhibiting the TGFβ and notch pathways in parallel to activating the Wnt 
pathway using small molecule inhibitors[89]. For neural differentiation, ES colonies 
were split in a 1:8 ratio onto matrigel-coated plates. Neural differentiation was 
initiated by changing media to neural induction medium (NIM) comprising of 
DMEM/F12 and Neurobasal media in a 1:1 ratio (Invitrogen), N2 supplement 1% v/v 
(Invitrogen), B27 supplement without vitamin A 2% v/v (Invitrogen), 2 mM L-
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glutamine (Invitrogen), SB43542 3 µM (Tocris), CHIR9921 4 µM (Calbiochem) and 
Compound E 0.1 µM (Calbiochem). Colonies were allowed to differentiate for 8 days 
into NSC colonies with media changes every other day. Neural colonies were then 
dissociated using Accutase into single cells and plated onto Matrigel in NPC media 
comprising of DMEM/F12 and Neurobasal media in a 1:1 ratio (Invitrogen), 1x N2 
supplement (Invitrogen), 1x B27 supplement without vitamin A, 2 mM L-glutamine , 
SB43542 2 µM, CHIR9921 3 µM, bFGF 20 ng/ml, EGF 20 ng/ml. Rock inhibitor 
(5µM) was used in the initial 2 passages to enhance cell survival. NSCs were 
routinely passaged in NPC media onto matrigel. 
For neuronal differentiation, NSCs were plated onto poly-lysine/laminin coated plates 
at a density of 50,000 cells/cm2 and media was changed to neuronal differentiation 
medium (DMEM/F12 and Neurobasal media in a 1:1 ratio, 1x N2 supplement, 1x 
B27 supplement, 2 mM L-glutamine, BDNF 10 ng/ml, GDNF 10 ng/ml). 
Neuron-astrocyte co-culture: Normal human astrocytes were obtained from Lonza 
and plated onto poly-lysine/laminin coated plates at a density of 10,000 cells/cm2 in 
complete astrocyte medium (Lonza). Next day, NSC derived from H9 cells were 
plated onto the astrocytes and neuronal differentiation was induced as described 
above. NSCs were allowed to differentiate for 2 weeks before staining them with 
NeuO. 
Cell staining and imaging conditions: All cells were stained with 500 nM of NeuO 
compound or derivatives for 1 hour in serum-free media. This was followed by 
washing in growth media for 1 hour followed by imaging using a 470nm/560nm filter 
or the FITC filter. For time lapse imaging of primary neurons and differentiating 
neurospheres, images were acquired using the Nikon biostation at intervals of 30 
minutes for up to 36 hours. For whole neonate brain staining and high magnifcation 
confocal imaging, cells were imaged using the LSM 5 Duo confocal microscope.  
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Time lapse imaging of rat hippocampal neuron: Primary dissociated 
rat hippocampal neurons (E18) were cultured on laminin-coated cover glass and 
stained at 3 DIV with 200 nM of NeuO in neurobasal medium (Invitrogen). After 5 
min in a CO2 incubator, the whole medium was exchanged with fresh neurobasal 
medium and stored for additional 30 min in the incubator. Subsequently, the stained 
neurons on cover glass was placed in a live cell imaging chamber (Live Cell 
Instrument, South Korea) embedded into laser scanning confocal microscope 
(Olympus FV 1000) system with 20x objective lens (NA = 1.0) for time lapse 
fluorescence imaging. The live cell imaging condition with 5 % of CO2 and 37°C 
conditions was remained while the fluorescence images were taken with a filter set of 
488 nm for excitation and 505-605 for emission and 1 min of acquisition time 
interval. 
Image analysis: For the analysis of neuronal morphology, the images of 30 wild type 
or NeuO sorted single neurons were skeletonised using the Simple Neurite Tracker 
plugin on ImageJ. Each skeletonised image was then analyzed using the Scholl 
Analysis and FracLac plugin.  
Immunocytochemistry: Cells were fixed in 4% PFA and permeabilized with 0.1% 
Triton-X (Sigma). Mouse cells were identified using the following markers at the 
respective dilutions: astrocytes - GFAP (DakoCytomaton) 1:1,000, neurons - β-III-
tubulin (Sigma) 1:1,000 and oligodendrocytes (Millipore) 1:500, NeuN (Millipore) 
1:500, NCAM (Millipore), MAP2 (Millipore), vGLUT (Millipore), tyrosine 
hydroxylase (Abcam), serotonin and GAD67. Human cells were identified using the 
following markers at their respective dilutions: astrocytes – S100β (Sigma) 1:500, 
neurons - β-III-tubulin (Covance) 1:500.  For secondary antibody staining, anti- 
mouse Alexa Fluor 546 IgG, anti-rabbit Cy5 IgG and anti-mouse Alexa Fluor 488 
IgM (Invitrogen) 1:1000 were used.  
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Cell viability assay: Neuronal cell viability was measured in the presence of 
increasing concentrations of NeuO using the MTS assay kit (Promega). 
Electrophysiology:  For whole-cell, patch clamp electrophysiology, artificial 
cerebrospinal fluid (ACSF) was used as external bath solution, containing (in mM): 
124 NaCl, 3 KCl, 1.3 NaH2PO4, 10 dextrose, 2 MgCl2, 2 CaCl2, 10 HEPES (pH 7.3-
7.4).  Recording pipettes (4–6 MΩ) were filled with the internal solution, containing 
the following (in mM): 140 CsCl, 4 NaCl, 0.5 CaCl2, 10 HEPES, 5 EGTA, 2 
MgATP, 0.4 Na3GTP (pH 7.2-7.3, osmolality 290 mOsm).  Series resistance smaller 
than 20 MΩ and capacitance higher than 40 pF were analyzed.  Data were digitized at 
40 kHz and filtered at 2 kHz using Axon multiclamp 700B amplifer and Digidata 
1440 (Axon instruments).  Unpaired Student’s t-test was used for statistical analysis.  
Flow cytometry and cell sorting analysis: All samples were analyzed and sorted 
using the MoFlo XDP under the FITC emission channel. For gene expression 
analysis, approximately 100,000 cells were sorted and the RNA was extracted using 
the RNasy Kit (QIAGEN). 
Gene expression: The gene expression of NeuO sorted cells was measured using the 
Power SYBR® Green RNA-to-CT™ 1-Step Kit (Applied Biosystem) on a 
StepOne™ Real-Time PCR System (Applied Biosystems). The sequences of primers 
used are as shown below. mRNA levels of the below genes were normalized to 
GAPDH expression levels using the Q-gene relative expression software tool. 
Target Protein Primer Sequence 
GAPDH F1: aagggctcatgaccacagtc 
R1: ggatgcagggatgatgttct 
β-III-tubulin F1: tgaggcctcctctcacaagt 
R1: ggcctgaataggtgtccaaa 
 
Zebrafish staining: 4-dpf zebrafish were immersed in 10 µM of NeuO for 30 mins. 
The zebrafish was then rinsed and anaesthesized with tricaine before mounting in low 
melting agarose for imaging. 
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Mouse Brain Slice Preparation:  All animals used for slice preparation were four 
month old male C57BL/6 mice obtained from the Jackson Laboratory (Bar Harbor, 
ME). All animal protocols were approved by the IACUC of Columbia University. For 
substantia nigra coronal slice preparation artificial cerebrospinal fluid (ACSF) 
containing (in mM): 125 NaCl, 2.5 KCl, 26 NaHCO3, 0.3 KH2PO4, 2.4 CaCl2, 1.3 
MgSO4, 0.8 NaH2PO4, 10 Glucose (pH 7.2-7.4, 292-296 mOsm/l).  Slices were 
allowed to recuperate at 32°C for 30 min followed by 30 min at room temperature. 
For hippocampal slice preparation, mice were decapitated and acute 300 μm thick 
horizontal slices were cut on a vibratome at 4°C oxygenated (95% O2, 5% CO2) low 
calcium ACSF solution containing (in mM): 10 NaCl, 2.5 KCl, 25 NaHCO3, 0.5 
CaCl2, 7 MgCl2• 6H2O, 1.25 NaH2PO4 •H2O, 10 Glucose, 180 Sucrose (pH 7.2–7.4, 
292–296 mOsm/L) to decrease excitotoxicity. Slices were then allowed to recuperate 
at 32°C for 30 min in ACSF containing the following (in mM): 125 NaCl, 2.5 KCl, 
25 NaHCO3, 2 CaCl2, 1 MgCl2 • 6H2O, 1.25 NaH2PO4 • H2O, 10 Glucose (pH 7.2–
7.4, 292–296 mOsm/L), and then transferred to another container with the same 
ACSF composition and allowed to cool to room temperature over 30 min before use.  
For two-photon imaging, slices were transferred to an imaging chamber (QE-1, 
Warner Instruments, Hamden, CT), held in place with a platinum wire and nylon 
custom made holder, and superfused (1-3 ml/min) with oxygenated ACSF. NeuO (1 
µM in ACSF) was loaded into the slice during 45 min incubation at room temperature 
in oxygenated ACSF. Slices were allowed to wash in the perfusion chamber for 15 
min before imaging.  Fluorescent structures were visualized at depths greater than 30 
µm in the slice using a Prairie Ultima Multiphoton Microscopy System (Prairie 
Technologies, Middleton, WI) with a titanium-sapphire Chameleon laser (Coherent) 
equipped with either a 60 X 0.9 NA or 10 X 0.3 NA water immersion objective. It 
was necessary to image at depths below 30 µm in order to visualize NeuO stainined 
cell bodies, especially in the hippocampus where the cell bodies on the surface of the 
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slice likely die due to the excessive excitotoxicity generated during hippocampal 
slicing.  
NeuO was excited at 920 nm (850 nm for the 10 X objective, due to infrared 
limitations of this objective) and imaged using an emission range of 570-640 nm.  
Images were captured in a 16-bit 112 x 112 μm field of view for 60 X and a 1347 x 
1347 μm field of view for 10 X at a 1024 x 1024 pixel resolution and a dwell time of 
10 μs/pixel using Prairie View software. 
Formulation and intravenous injection of NeuO: NeuO was prepared to 2mM in 
PBS with 10% DMSO and 2% Tween-20 and 0.2 ml was injected into each 8-10 
week old C57BL6 mouse via the tail vein. The mice were sacrificed after 1 hour and 
the brains and spinal cords were extracted and flash frozen. Tissues were 
cryosectioned at a thickness of 12 µm. Immunostaining for tissue slices was carried 
out using methods as indicated above.  
Quantum yield measurements. Quantum yields were calculated by measuring the 
integrated emission area of the fluorescent spectra in its respective solvents and 
comparing to the area measured for Acridine Yellow (ΦF = 0.47) in EtOH (η = 1.361) 






































where F represents the integrated intensities of the emission spectra, n is the 
refractive index of the solvent, and f is absorption factor (
Af  101 , where A = 
absorbance) at the excitation wavelength selected for reference and samples. 
Emission was integrated between 460 and 750 nm. 
*For chemical sytheisis methods, please refer to the thesis of Er Jun Cheng, titled 





In vitro staining 
NeuO shows specificity for neurons 
The fluorescent small molecule probe, Neuron Orange (NeuO, ex/em = 
460nm/555nm, Figure 4.2.1a and b, Appendix 8.2) was identified from our primary 
neural screens as being specific for primary neurons. NeuO stains the cytoplasm and 
neurites of neurons, with the compound appearing to be localized in boutons along 
each neurite (Figure 4.2.1c).  
                                                           
 











Figure 4.2.1. (a) Structure of the neuron specific dye – NeuO (b) Excitation and 
emission spectrum of NeuO (c) Confocal images of a NeuO stained neuron. Scale 
bar: 20 µm (d) NeuO stains neurons specifically – NeuO positive cells are positive 
for the neuron marker, β-III-tubulin whereas other neural cell types (GFAP –
astrocytes, O4 – oligodendrocytes) are not stained. Scale bar; 20 µm 
To confirm that NeuO is capable of discriminating neurons from other neural cell 
types, the compound was applied to mixtures of primary neural cells and imaged 
(Figure 4.2.1c). This was followed by immunostaining with antibodies for different 
neural cell types (neurons - β-III-tubulin, astrocytes - Glial Fibrilliary acidic protein, 
(GFAP), oligodendrocytes -O4). A clear neuronal population was also visible when 
mixed cultures of neonatal and adult brain cells were stained with NeuO and 
analyzed by flow cytometry (Figure 4.2.2). 
To further validate the neuronal cell type, NeuO positive cells were also 
immunostained with other known neuron markers such as NeuN, NCAM and MAP2 
(Figure 4.2.2c). NeuO positive cells were shown to be very specific for neurons 
without staining other neural cells types in dense cultures of cells derived from 





              
Figure 4.2.2. (a) NeuO positive populations are clearly segregated in the scatter 
profiles of primary neural cells derived from the neonatal and adult mouse brain. (b)  
β-III-tubulin expression was analyzed in the Whole, Bright and Dim fraction of cells 
sorted from neonate or adult NeuO sorted cells. (c) NeuO positive cells are also 
positive for other neuronal antibody markers such as NeuN, MAP2 and NCAM. Scale 










NeuO appears to stain all neuronal cell types 
Neurons have been classified into a many of subtypes depending on their localization, 
morphology and other physiological properties. GABAergic, glutamatergic, 
dopaminergic/noradrenergic and serotinergic neurons are examples of neuron 
neurotransmitter subtypes that are both stained by NeuO as demonstrated by live cell 




Figure 4.2.3. (a) Subtype immunostaining of NeuO positive neurons. NeuO stained 
neurons can be GABAergic (GAD67), glutamatergic (vGLUT), dopaminergic 
(Tyrosine hydroxylase) or serotinergic (serotonin). Scale bar; 20 µm. *Yellow 
astericks denote cells that are both NeuO and antibody subtype positive. Red 
astericks denote cells that are NeuO positive but antibody negative. 
Due to the large size and sensitivity of the brain, two-photon ex vivo or in vivo 
imaging of the brain has become increasingly popular over the years due to its high 
penetration with low photobleaching and phototoxicity. Two photon imaging also 
provides high resolution and efficient fluorescence detection[13], thereby making it 
possible to image cells in the live brain. To examine NeuO labelling in brain tissue, 
two-photon microscopy imaging was carried out in the hippocampal regions of mouse 
brain slices since these regions are densely populated with glutamatergic neuronal 
cell bodies which can be easily identified by their characteristic s-shaped 
organization.  NeuO densely labelled the principle cell layer of the DG, the stratum 
granulosum, and sparsely labelled the principle cell layer of CA1, the stratum 
pyramidale (Figure 4.2.4a). The cell labelling pattern was similar to P1 neonate 
whole brain staining where clear neuronal structures were visible when viewed under 
confocal microscopy (Figure 4.2.5a). This staining pattern differed from the one of 
Sulforhodamine 101 (SFR 101), which stains live astrocytes [90] (Figure 4.2.5a).  
Neuronal specificity was also effectively demonstrated in neurons derived from 
human embryonic stem cells, using the β-III-tubulin marker for neurons and S100β 
marker for astrocytes (Figure 4.2.4b). The human neurons showed a similar staining 
pattern to the mouse neurons, with the dye particularly densely concentrated in the 
perinuclear region of the cell (see yellow arrow). 
In a 3 dpf zebrafish larvae, neuron specific staining  was observed in the neuromasts 
[91]. Neuromasts make up part of the lateral lines system in zebrafish, which are 
comprised of a set of rosette-like organs near the head and the body [92]. They are 
highly innervated by sensory afferent neurons cells thus enable the fish to sense 
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changes in water direction. Enhanced NeuO signal observed in the neuromasts 
suggests that its neuronal specificity is conserved across species (Figure 4.2.4c).  
 
 
Figure 4.2.4. (a) Left: NeuO staining in the hippocampus shows dense labelling. 
Scale bar; 200 µm. Right: NeuO staining of cell bodies in the dentate gyrus shows a 
perinuclear labelling pattern. Scale bar; 20 µm. (b) NeuO also stains for neurons in 
mixed neural cultures of human cells. β-III-tubulin (green) was used as a marker for 
neurons, S100β(red) for astrocytes and Hoechst for nuclei. Scale bar; 20 µm (c) 
Zebrafish neuron staining by NeuO. NeuO labels intensely the neurons located at the 
body surface, which include neurons of the nose (arrow), of the internal ear (dashed 
arrow) and of the neuromasts along the lateral line (arrowhead) of the 3-dpf larvae. 
Scale bar; 100 µm. *Brain slice images courtesy of P. Merchant and M. Dunn, 
Zebrafish image courtesy of Dr. Teoh Chai Lean 
Time lapse studies of NeuO stained bouton movement indicate that NeuO stained 
boutons are moving at an average speed of 0.0022 µm per second, bidirectionally 
(Figure 4.2.5b). This speed is consistent with studies of axonal transport, falling into 
the category of slow component b transport which involves the movement of 






Figure 4.2.5. (a) Neonate brain confocal staining with NeuO and Sulforhodamine 
101. The neuronal staining pattern or NeuO is distinct compared to the astroglia 
staining of Sulforhodamine 101. Scale bar; 10 µm. (b)  Time lapse imaging of bouton 
movement in NeuO stained neurons show that the boutons move at an average speed 
of 0.0022 µm/s bi-directionally. 
NeuO may be applied to track neuronal differentiation and development in vitro 
Given the specificity of NeuO for neurons, we were interested to determine if the dye 
was able to identify newborn neurons from differentiating neural stem cells or 
visualize dendritic process branching on freshly plated neurons. A series of time lapse 
images of freshly seeded neurons stained with NeuO shows the cell contorting 





are heterogenous mixtures of stem cells and neural cells at different stages of 
differentiation. To identify newborn neurons, NeuO was also applied to neurospheres 
induced to neuronal differentiation and imaged using time lapse microscopy. Images 
show brightly stained neurons emerging from the neurosphere and migrating around 
its periphery (Figure 4.2.6, Supplementary Video 4.2.2) 
 
Figure 4.2.6. Time lapse imaging of a neurosphere induced towards neuronal 
differentiation 
While neuron specific staining remains intact after the stained cells are fixed by 
paraformaldehyde, the dye is significantly washed out from the cells upon membrane 
permeabilization or washing with organic solvent (Figure 4.2.7a). This is distinct 
from conventional Nissl and Golgi staining, which require membrane 
permeabilization by detergents before the stains can be visualized in neurons. 
However, NeuO is not specific for neurons in dead cells as seen from the fact that the 










   
Figure 4.2.7. (a) NeuO staining is significantly washed out with triton-x or methanol. 
Scale bar; 20 µm. (b) The leftmost image shows neurons differentiated from 
neurospheres stained with NeuO when alive. Middle: Fixed cells stained with NeuO 
when alive remain selectively stained when fixed with paraformaldehyde. Right: 
NeuO no longer stains specifically for neurons when the dye is applied after 
paraformaldehyde fixation. Scale bar; 25 µm. 
NeuO does not affect cell viability and functionality 
For the assessment of neuron function, the eletrophysiological activity of control and 
NeuO stained neurons was measured (Figure 4.2.8). NeuO stained neurons did not 
show significiant differences in electrophysiological spiking, resting membrance 
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Figure 4.2.8. (a) Examples of action potentials (middle and bottom traces) by current 
injection (top traces) in neuron treated with or without NeuO (1 μM).  (b) 
Quantification showing relationship between injected current (x-axis) and number of 
action potential spike (y-axis) with or without NeuO (1 μM).  (c-e) Quantification of 
resting membrane potential (c), capacitance (d), and membrane resistance (e), 
respectively, in neurons treated with or without NeuO (1 μM).  Values shown 
represent mean±S.E.  
To confirm that NeuO does not affect cell viability and functionality, an MTS assay 
was carried out on cultures of primary neurons from 0 to 10 µM of dye concentration 
for up to 24 hours. Figure 4.2.9a shows that neuronal cell viability is not affected by 
higher concentrations of dye for up to 24 hours suggesting that our dye is unlikely to 
be cytotoxic to neurons. Time lapse imaging was also carried out on freshly seeded as 
well as mature neurons (Supplementary Video 4.2.3) which show neurons maturing 
normally in culture and interacting with other cells.  
To determine if NeuO sorted neurons were able to form dendritic processes normally, 
non-sorted and NeuO sorted cells were measured for ramification index, average 
intersecting points, average branch length and fractal dimensions (Figure 4.2.9b). 
Once again, there was no significant difference observed between the two samples 






Figure 4.2.9. (a) Primary neurons isolated from P-3 mouse brains were incubated 
with increasing concentrations of NeuO for 24 hours. Cell viability was measured 
using the MTS assay (Promega).  (b) WT (unsorted) and NeuO sorted neurons were 
measured for ramification index, average intersecting points, average branch length 
and fractal dimensions. No significant difference in these values was observed 
between WT and NeuO sorted neurons. 
 
In vivo studies of NeuO in the mouse brain 
To determine if our dye is selective for neurons in vivo, we administered 2mM of 
NeuO (2% Tween-20, 10% DMSO) by intravenous injection into mice and harvested 
the tissues of the CNS for analysis after 1 hour. Shorter or longer post-injection 
durations resulted in less than optimal staining (Appendix 8.2.3). Brains and spinal 
cord tissue isolated from NeuO injected mice showed clear NeuO signal in the 
neurons of the hippocampus, hindbrain and cortex (Figure 4.2.10a). The cell bodies 






the spinal cord (Figure 4.4.10a). Immunostaining with the neuronal marker, NeuN 
confirmed that the dye is specifically staining neurons in the brain and spinal cord. 
Control images were also taken from non-NeuO injected mice and imaged at the 
same exposure times (Figure 4.2.10b).  
The Nissl staining method utilizes the interaction of basic dyes such as cresyl violet 
with DNA and RNA, which are highly concentrated in the ribosomes and rough 
endoplasmic reticulum [94]. As cells that are active in protein synthesis, neurons 
usually have a large amount of rough endoplasmic reticulum in their cytoplasm, 
making them ideal for Nissl staining [95]. NeuO staining also showed a similar 
staining pattern with the Nissl dyes (Figure 4.2.10c). The successful detection of 
NeuO in the neurons of the brain and spinal cord demonstrate that the dye is effective 
in by passing the Blood brain barrier (BBB) and that neuronal specificity is conserved 

















Figure 4.2.10. Brain and spinal cord sections from mice injected intravenously with 
2mM of NeuO. Scale bar; 50 µm. (a) Images of NeuO injected mouse brain and 
spinal cord sections with their corresponding immunostained regions. (b) shows 
control images of the brain and spinal cord from the non-NeuO injected mice taken 
with the same exposure times as NeuO injected mice. Scale bar: 50 µm.  (c) Brain 
sections from 1 hour NeuO injected mice were permeabilized for Nissl staining. The 
yellow arrows denote large neuronal cell bodies stained by NeuO which correspond 
to Nissl staining. Scale bar; 50 µm. 
NeuO stains peripheral nerves 
In addition to staining neurons of the CNS, we were also interested to see if the dye 
was effective in staining neurons of the peripheral nervous system (PNS). For this 
purpose, we isolated the sciatic nerve from NeuO injected mice. Fluorescence signal 
was strongest from the sciatic nerve at 10 minutes post injection and immunostaining 
of the nerve region showed that NeuO signal correlated with NeuN positive staining.  
The ability to stain nerves of the PNS has significant biomedical application, 
particularly for surgery purposes where identification of fine nerves in underlying 
tissue is critical to avoid accidental transsection. To test if our dye was suitable for 





this application, 200 µM of NeuO was applied to the exposed regions of the hind leg, 
chest cavity and axilliary brachial plexus region of a mouse and imaged continuously 
for 5 minutes, during which the tissue was flushed briefly with PBS post dye 
application. Over the duration of 5 minutes, NeuO staining highlights the structure of 
major nerves (sciatic and phrenic nerves) as well as several other finer nerves not 
visible to the naked eye. This strongly supports the use of NeuO, not only as a neuron 
specific dye for in vitro and in vivo applications but for other potentially useful 










Figure 4.2.11. (a) Time course sciatic nerve staining from a NeuO IV injected 
mouse. Scale bar; 20 µm.  (b) Nerve staining from a NeuO IV injected mouse and its 
corresponding immunostaining. Scale bar; 20 µm. (c) Upper panel shows the hind leg 
region of the mouse before and after the application of 200 µM of NeuO. The sciatic 
nerve and its corresponding branch can be visualized (yellow arrows) post 
application. Note that the artery running alongside it remains unstained. Middle panel 
shows the staining of the left and right phrenic nerves with NeuO. A fine nerve 
running between the two phrenic nerves can also be visualized on the surface of the 
diagphragm post-staining (yellow arrows). Lower panel: NeuO staining of the 
axillary brachial plexus region – clusters of nerves are visible post-staining (yellow 






The hydroxyl group is critical for neuronal specificity 
As mentioned in Chapter 2, Section 2.4, the final NeuO structure was optimized 
during early screening for the incorporation of the hydroxyl motif based on the 
observation that it conferred better neuronal specificity. In an attempt to further 
delineate the chemical motifs that are critical for its neuronal specificity and binding 
by extensive modification of the acetyl, amine and triazole side chains (Figure 
4.2.12), a total of 22 derivatives were eventually synthesized for Structure activity 
relationships (SARs) testing with varied modifications to the 3 different side arms 
(*for detailed information on structures, refer to thesis of Er Jun Cheng, titled ‘The 
Evolution of Fluorescent Probes’).  
 
Figure 4.2.12. The above shows the structure of NeuO and its different side groups. 
*Figure courtesy of Er Jun Cheng. 
 
Modifications to the hydroxyl, amine and triazole arms of NeuO were carried 
out with the following aims: 
(1) To determine critical motifs for neuronal cell specificity 
(2) To determine critical carbon chain lengths affecting cell permeability 
(3) To incorporate reactive groups into the mother structure for binding target 
pulldown 
(4) To analyze how corresponding changes in clogP values affected the ability of the 




Based on our observations to how these changes affected neuron specific staining, it 
was observed that (1) The hydroxyl motif on the hydroxyl arm is the single most 
critical motif for neuronal specificity, (2) Of the 3 motifs, the triazole arm is the least 
essential for neuronal specificity and (3) The amine arm has some role to play in 
maintaining neuronal selectivity but is sufficiently open for some modification.  This 
suggests that as long as the hydroxyl motif is conserved, it is possible to modify the 
other side arms of the molecule for other purposes such as the inclusion of affinity 
motifs for improved binding or changing the hydrophobicity of the dye by including 
more hydrophobic or hydrophilic motifs.  
Modification for stabilized binding and target identification – NeuO-V 
 In conditions where harsh tissue or cell processing protocols may be required, it may 
be desirable for NeuO staining to persist to enable co-staining with other cell 
markers. For this purpose, a vinyl motif was incorporated into the NeuO structure at 
the amind arm to make the derivative NeuO-V. Vinyl motifs have been shown to 
react with [96] cysteine residues in biological systems forming covalent bonds that  
are more resistant to downstream cellular processing and proteomic analysis.  
NeuO-V was found to have neuronal specificity equivalent to NeuO thus indicating 
that neuronal binding is not affected by the inclusion of the vinyl motif. Under 
conditions of 0.1% Triton-X and methanol washing post 4% paraformaldehyde 
fixation, NeuO-V staining in neurons survived strongly although there was a slight 
change in staining pattern as seen from the translocation of staining pattern to include 
the neuronal nuclei (Figure 4.2.13a). This change in staining pattern is likely an 
artefact of fixation as described by Schnell et al. [97]. The ability of NeuO-V signal 
to survive permeabilization enabled co-immunostaining with β-III-tubulin and GFAP 
(Figure 4.2.13b). The results clearly show that all NeuO-V positive cells are co-
localized with β-III-tubulin positive cells whereas GFAP and NeuO-V staining is 
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mutually exclusive. This supports our earlier observations that NeuO stains all 
subtypes of neurons.  
 
  
Figure 4.2.13. NeuO-V exhibits covalent binding in conditions of organic solvent 
washing or paraformaldehyde fixation. Scale bar; 20 µm. (a) NeuO is washed out in 
all conditions but clearly neuronal specificity is maintained in NeuO-V stained cells 
(b) NeuO-V stained neurons were fixed, peremabilized and immunostained for β-III-
tubulin or GFAP. Scale bar; 25 µm. 
Its unique binding properties in vitro suggest that the vinyl affinity motif may be 
capable of achieving target binding. To apply this to target identification, neuron 
enriched cells were stained with NeuO-V and lysed for 1D SDS-PAGE and 2D gel 
IEF and SDS-PAGE separation. NeuO-V dye binding was sufficiently stable in SDS-







Target identification and validation 
Target identification is a key point of interest for researchers for small molecule 
binding. To achieve this for NeuO-V binding in neurons, neuron enriched cells were 
stained with 500 nM of NeuO-V 2 hours before lysis and analysis by IEF separation 
and 2D SDS-PAGE. Fluorescence scanning of the 2D gel revealed two major clusters 
of spots which were excised and analyzed by mass spectrometry (Figure 4.2.14). The 
upper clusters of spots (#1 and #2) were identified as heterogenous nuclear 
ribonucleoprotein (hnRNP H) and mitochondrial ATP synthase β respectively (Table 
4.2). The lower cluster of spots were identified as (#4) mitochondrial ATP synthase , 
(#3) Fatty Acid binding protein 7 (FABP7) and (#5) S16 ribosomal protein 
respectively (Table 4.2). FABP7 was ruled out as a binding target based on the fact 
that it is likely to be due to the fact that the neuron enriched samples were derived 
from neural stem cells.  
.  
Figure 4.2.14. 2D SDS-PAGE of neuron enriched cell lysate stained NeuO and their 
corresponding proteins as identified by mass spectrometry.  
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5 P51880 (1) Fabp7 15.2 383 100 5 
Peptide data was searched against the Swiss-Prot mouse data base.  For the reported 







 and number of peptide 
matches. A peptide false discovery rate of 0.05 was applied and proteins with a score 
higher than 55 are shown. 
*Only protein scores greater than 55 are significant (p<0.05). 
Target Validation 
The role of a mitochondrial ATP synthase as a background binding target was 
confirmed by high magnification analysis of NeuO stained neurons co-stained with 
Mitotracker (Figure 4.2.15). Heterogeneous cultures of neural cells stained with 
NeuO alone showed background staining in astrocytes reminiscent of mitochondrial 
staining (Figure 4.2.15). This showed staining pattern showed relatively higher 
correlation with mitotracker staining as compared to other cell organelle trackers such 
as lysotracker, golgi tracker and the RNA dye, F22 (Figure 4.2.15).  
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Figure 4.2.15. The above shows the staining patterns between NeuO and different 
cell organelle trackers. Scale bar; 10 µm. The R values for Pearson’s correlation 





Although mitotracker staining contributed to some co-staining with NeuO, there was 
an additional peri-nuclear staining with the compound appearing to localize in 
granules that failed to co-localize with mitotracker suggesting the presence of another 
binding target contributing more significantly to neuronal specificity (Figure 4.2.15). 
To validate the role of the other identified proteins from 2D SDS-PAGE and mass 
spectrometry, gene expression analysis and antibody co-staining was carried out. The 
gene expression of cells derived from adult whole brain NeuO sorted cells were 
analysed for the expression RPS16, ATP5 and hnRNP H using β-III-tubulin and 










Figure 4.2.16. (a) shows the control gene analysis from whole, bright and dim 
population sorting from NeuO stained adult brain cells for β-III-tubulin, GFAP and 
ATP5. The corresponding gene expression measurements of the 2 main targets 
(Hnrnph and Rps16) are shown in Figure 5d. An unpaired two-tailed t test was 
performed for all genes (* p<0.05 and **p<0.01). Values shown represent mean 
±S.D. (b) Immunostaining of NeuO-V stained neurons with anti-RPS16 and anti-
hnRNP H antibodies. Scale bar; 20 µm. 
To further analyze the binding of NeuO-V with RPS16 and hnRNP H, myc-dkk-
RPS16/hnRNP H vectors were expressed into 293T cells and the cells stained with 
NeuO-V for SDS-PAGE and western blot. Flow cytometry analysis of the cells 
showed that RPS16 and hnRNP H transfected cells were brighter than control (non-
transfected cells) (Figure 4.2.17a). When the cells were analyzed by SDS-PAGE, 
RPS16 stained cells appeared to be more strongly stained by NeuO-V (Figure 
4.2.17b). In addition when the cells were analyzed by western blotting, the RPS16 
positive band more closely matched the NeuO-V positive band size as compared to 
hnRNP H. This suggests that RPS16 contributes more significantly to the neuronal 
specificity of NeuO-V compared to hnRNP H. Also our observation was that hnRNP 
H antibody staining is almost exclusively nuclear, whereas NeuO staining does not 
stain the nucleus significantly. This suggests that while NeuO-V may have affinity 




for the hnRNP H protein in the cell lysate, it does not contribute to neuronal 
specificity as much as RPS16. 
 
 







Figure 4.2.17. (a) Flow cytometry histogram of RPS16 and hnRNP H overexpressing 
293T cells stained with NeuO-V. (b) From left to right – Gel run of the 
corresponding NeuO-V stained cell lysates (Lane 1: Control, Lane 2: RPS16 
overexpressing, Lane 3: hnRNP H overexpressing). Western blot for hnRNP H, 
































The discovery of the small molecule fluorescent live neuron specific probe, NeuO 
marks a milestone in neuron staining methodology. To date there are no small 
molecule dyes capable of labelling live neurons specifically that exert their effect in 
vitro and in vivo. Conventional neuron staining methods such as Nissl, Golgi or 
antibody staining still rely heavily on harsh cell permeabilization methods that 
compromise cell viability. A major advantage of NeuO lies therein in its potential of 
use as a live cell imaging tool in vitro, making it possible to visualize the activity of 
live neurons alone or in tandem with other fluorescence markers. Examples of such 
studies include studying the dendritic development of neurons in vitro or the 
differentiation of neurons from neural stem cells. NeuO may even be used in 
combination with our microglia specific dye, CDr10 for the imaging of neuron-
microglia interactions and possibly even neuronal pruning in vitro.  
Another very useful application of NeuO would be for the staining of peripheral 
nerves or nerves of the retina. While NeuO was discovered from a neural screening 
platform - preliminary studies show that the dye also has the capacity to stain neurons 
of the peripheral nervous system. Because different types of neurons are important 
functional units throughout the body, this gives it extensive scope for further 
development particularly as a tool for nerve visualization during surgery. The 
versatility of this dye is such that it can be adapted to a multitude of applications 
depending on the needs of the researcher and we anticipate that NeuO will form the 
basis for the development of many novel neuronal assays to come. 
A drawback of NeuO lies in its emission wavelength, which at 555 nm overlaps 
slightly with the commonly used commercial dye emission wavelengths of FITC 
(Emission: 520 nm) and TRITC (Emission: 560 nm). This limits the number of other 
marker molecules that can be potentially used in conjunction with this dye. 
Fluorescent protein conjugates with GFP can still potentially be used with NeuO 
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although spectral unmixing is required to discern the two signals without interference 
from emission overlap. Further SARs and chemical engineering studies are underway 
to determine if the structure of NeuO can be whittled down to its bare minimum 
formulation for specificity. Based on this new structure, a supporting dye structure 
may be rebuilt that is tunable to different emission wavelengths thus allowing the dye 
to be custom formulated.  
Target identification studies using the NeuO derivative, NeuO-V, have identified the 
S16 ribosomal protein and heterogenous nuclear ribonucleoprotein as the main 
binding targets, with the former contributing more significantly to neuronal 
specificity. Background staining in other cells is can be attributed to non-specific 
binding to the ATP synthase protein. These findings are consistent with reports in the 
literature that certain ribosomal associated proteins are over expressed in neurons. 
The active role of neurons in translation within the neuron body, axon and dendrites 
is an established process that is critical for neuron function [98]. Traditional neuron 
staining methods such as Nissl have long relied on the affinity of basic dyes for 
nucleic acid and ribosomal nucleic acids [94]. Based on microarray and gene 
profiling studies, neurons are also known to over express numerous ribosomal 
proteins in the cell body compared to other cells [99]. In a publication by Min et al., 
the authors identified a generally expressed hnRNP F that is involved in the formation 
and function neural specific  pre-mRNA complexes [100].  This suggests that 
ubiquitously expressed ribosomal proteins are involved in cell specific expression.  
However, there is little if any published literature that reports the neuron specific 
expression of increased levels of RPS16. Studies on the protein structure of the 40S 
ribosomal subunit point to the role of RPS16, which together with RPS16 and RPS18 
appear to constitute a critical binding pocket in the head of the ribosome [101], 
although the nature of the binding interactions remain unclear. However, it is also 
important to note that ribosomal proteins are highly promiscuous and their 
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involvement in many other protein complexes and cell machinery means that we 
cannot rule out NeuO binding to other types of RNA-protein complexes. Thus it is 
likely that there is still extensive study required on the role of RPS16 as a protein in 
the cell as well as in neurons before the true nature of NeuO binding is elucidated. 
 
CONCLUSION 
The novel neuron specific dye, NeuO has been demonstrated to be exquisitely 
specific for neurons in the CNS and can be applied for a variety of imaging, cell 
isolation and in vivo imaging techniques. It has advantages over most existing neuron 
labelling techniques primarily because it achieves specific labelling in live cells 
without compromising cell viability and can be administered in the whole animal. Its 
neuronal targeting ability is inherent in the dye structure thus superseding existing 
methods of manual loading and fluorescent protein expression. It can also penetrate 
the live neuron easily and be used for a variety of time lapse imaging and isolation 
applications, with the neurons remaining viable post-staining.  
Thus far NeuO remains a generic neuron marker with no affinity for any specific 
neuron subtype. This is useful for the study of neuronal networks and the monitoring 
of neuronal health. Its cross species specificity may be applied for the study of 
neurons in species for which transgenic models are not available (i.e. Rat, Human). It 
is hoped that continued efforts in the screening of the DOFL will continue to disclose 
new and novel structures with specificity for different neuronal subtypes that may one 
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5.1 Introduction to neural stem cells 
 Neural Stem cells 
The cells of the brain cannot be discussed without mention of the elusive neural stem 
cell, which forms the basis for the development of all astrocytes, oligodendrocytes 
and neurons. Neural stem cells (NSCs) in the mammalian brain are characterized by 
their ability to self-renew and form free floating spheres in culture [102]. These 
neurospheres consist of a heterogeneous mixture of neural stem cells, neural 
progenitors as well as cells that are committed to terminal lineages [103]. The ability 
of neural stem cells to regenerate and differentiate into neurons, astrocytes and 
oligodendrocytes even into adulthood make them much coveted tools in the field of 
regenerative medicine, where it is hoped they can be utilized to regenerate neurons 
that have been lost as a result of disease or injury [104].  
NSCs are most abundant in the developing foetal brain and persist throughout whole 
life generating new neurons and glia continuously. The study of NSCs from adult 
brain tissue is particularly challenging because the cells are low in number (0.1-1%) 
and require specialized and tedious cell preparation techniques which have limited 
yield [74, 105]. As such, considerable research has been focused on developing 
isolation techniques and identifying markers for these elusive cells.  
Neural stem cell labelling and isolation 
Given their low abundance in the brain, especially by adult stage – neural stem cell 
labelling and isolation methods are a challenge. Commonly used methods of NSC 
labelling either involve antibody labelling with cell surface markers or fluorescent 
protein expression with the desired marker of interest. Presently, the most widely 
used cell surface markers for the isolation of NSCs are CD133 and SSEA-1 [106, 
107]. Separation is usually achieved by antibody labelling and magnetic bead 
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separation or fluorescence detection of live labelled cells. The small molecule 
fluorescent dye, AldeFluor, although originally designed for hematopoietic stem cell 
isolation, has also been reported to be applicable for neural stem cell isolation [108]. 
This is based on its selectivity for the metabolic enzyme, aldehyde dehydrogenase 
(ALDH) which has also been reported to be enriched in NSCs [108] as well as in 
hematopoietic stem cells [109]. Cells isolated by these methods have been 
demonstrated to be self-renewing and tripotent [110, 111]. 
Using a combination of three NSC markers (CD133, SSEA-1 and ALDH), Obermair 
et al. reported several subpopulations of neural stem/progenitors within the brain 
[112]. Fischer et al. also reported the isolation of NSCs from GFAP+/CD133+ cells 
from the adult brain [102]. On the other hand, other studies have shown that the 
expression of CD133 in NSC depends on developmental stage [113] and a significant 
portion of NSCs do not express this marker [114]. Major obstacles to isolate NSCs 
continue to be the lack of NSC specific cell surface markers and tools to detect 
intracellular markers which are more specific both in the developing and mature 
brain.  
Neural stem cells are heterogeneous  
With the advent of new stem sources such as stem cell reprogramming and new 
methods of transdifferentiation, the field of neural stem cell research is rapidly 
evolving. It has becoming increasingly apparent that neural stem cells are far more 
heterogeneous than previously believed and transit between several intermediate 
progenitor stages before terminal differentiation [115]. Their cell fate is also highly 
dependent on cell fate and local environment, conditions which may not always be 
reproducible in vitro.  
The neurosphere assay, which involves the dissociation of brain cells into a single 
cell suspension and the subsequent formation of neural stem cell clusters, remains the 
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single most widely used assay for the assessment of neural stem cell proliferation and 
renewal capacity (Figure 5.1.1). Most neurosphere cultures are derived from primary 
cell preparations of embryonic brains and can be enriched through cell sorting by the 
above mentioned labelling methods. As they are primary cells, neurospheres can be 
thus be sub cultured only for a limited duration in vitro and require physical or 
chemical methods to dissociate the cell clusters.  
 
Figure 5.1.1 Detection and expansion of neural stem cells using the neurosphere 
assay. (a) When embryonic or adult primary CNS tissue is transferred to neurosphere-
generating conditions, both neural stem cells and non-stem precursor cells survive. 
(b) Following dissociation and replating, primary neurosphere–derived neural stem 
cells and non-stem precursor cells proliferate to form secondary spheres. (c) When 
plated at a clonal density, approximately 2.4% of cells generate a neurosphere. (d) 
When individual clonally derived neurospheres are mechanically dissociated into a 
single-cell suspension and plated into a single well (at one sphere per well), each 
sphere will generate about 50 secondary spheres. (e) Serial passage growth curves 
based on an actual bulk culture (black line), 50- fold expansion as determined by 
single-sphere dissociation data (red line) and a theoretical stem cell frequency of 
2.4% (blue line). Image adapted from [116]. 
A popular alternative source of neural stem cells for experimental testing are the 
mouse and human neural stem cells lines, NS5 [117] and RenVM [118] respectively. 
While these stem cell lines offer a useful renewable source of neural stem cells for 
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sub culture, they do not fully recapitulate the true heterogeneity of neural stem cells 
but rather, a subtype of neural stem cells frozen in a specific differentiation lineage. 
The neurosphere itself remains the most accurate representation of a neural stem cell 
due to its intrinsic heterogeneity [119].  
However their use remains fraught with limitations. Studies have shown that 
neurospheres are capable of fusing spontaneously with one another in culture, thus 
challenging the paradigm of the neurosphere as a clonal entity [120]. The use of 
markers such as CD133, Nestin, Hes1, Hes5, Sox2 etc has also been questioned since 
it appears that there are discrepancies in neural stem cell properties even within cells 
expressing a group of known neural stem cell genes [112]. Observed phenotypes and 
marker/gene expression depend heavily on the types of isolation markers utilized 
[121]. Current in vitro and  in vivo studies suggest that is it likely that multiple neural 
stem cell phenotypes exist in various quiescent or activated states, for which their 
proliferative and differentiation capacity are highly dependent on spatial and 
morphogenical cues depending on their local environment [119].  
Neural stem cells in regenerative medicine 
Our interest in neural stem cells lies in their regenerative potential and their ability to 
restore neurological and motor function after damage or disease. It is imperative that 
defects in neural stem cell development during embryogenesis result in devastating 
neurological impediments for which there is no cure. However harvesting the 
regenerative potential of neural stem cells in adulthood can be potentially useful for 





Figure 5.1.2. Diagram illustrating the isolation of neural stem cells from the fetal or 
adult brain and how it may be applied for cell replacement therapy. Image from 
[122]. 
With the advent of personalized medicine, studies have suggested that it may be 
possible to graft isolated neural stem cells back into the patient to compensate for lost 
CNS function [123]. Most of these studies have focused on the regeneration of 
dopaminergic neurons in Parkinson’s disease. In a study by Tønnesen et al., stem cell 
derived dopminergic neurons engrafted into the intrastriatal regions of animal models 
of Parkinson’s disease were able to induce behavioural recovery [124].  
The use of neural stem cell therapy also holds promise for those rendered immobile 
by spinal cord injury. In a study by Fujimoto et al., transplanted hip cells 
differentiated into neurons in the mouse model of spinal cord injury, enabling the 
functional recovery of hind limb motor function [125]. Further studies showed that 
these grafted cells were able to integrate effectively into neuronal circuits of 
surviving endogenous neurons thus facilitating restoration of motor function. The 
generation of neural stem cells, either by isolation from adult tissue or from iPS cells 
will contribute significantly to the field of regenerative medicine by making these 
endogenously rare cells available in greater numbers. As our understanding of these 
cells and their associated phenotypes continues to grow, the use of neural stem cell 




5.2 Prologue: CDr3, a neural stem cell specific probe 
Discovery, characterization and validation 
We developed the FABP7 binding fluorescent small molecule probe, CDr3 which is  
specific for mouse and human neural stem cells [24]. Its discovery was also based on 
a high throughput image based screen of 3,160 DOFL compounds on E14 mouse 
embryonic stem cell (mESC), E14-derived NSC (NS5), differentiated NS5 into 
astrocyte (DNS5) and mouse embryonic fibroblasts (MEF) (Figure 5.2.1). By 
tracking the fluorescence signal from the protein lysate and peptide analysis by 
MALDI-TOF/TOF MS and MS/MS analysis, the target protein was identified to be 










Figure 5.2.1. (a) Structure of CDr3. (b) Confocal image of CDr3 stained neural stem 
cells showing cytoplasmic localization. Scale bar, 10 µm. (c) MEF, D-NS5, NS5 and 
E14 cells were stained with CDr3. Only NS5 cells were selectively stained. Scale bar, 
50 µm. Images adapted from [24]. 
Due to its low molecular weight (Mr = 572) and high lipophilicity (cLogP = 8), CDr3 
is capable of diffusing passively through the cell membrane and is retained by 
FABP7-expressing NSCs leading to selective staining. There is extensive literature 
supporting the increased expression of FABP7 protein in neural stem cells [126]. 





system, with different subpopulations of progenitor cells restricted to individual fates 
[127]. Levels of FABP7 increase during embryonic mouse brain development, 
peaking at embryonic day 14 (E14) and decreasing exponentially from post-natal day 
one onwards [128]. At late embryonic and post-natal stages, a subpopulation of these 
radial glia give rise to NSCs that are implicated in adult neurogenesis [129]. FABP7 
has been found to play a critical role in NSC proliferation, neurogenesis, migration, 
neurite formation and synapse maturation [128, 130]. Dysregulated FABP7 signalling 
and expression has also been associated with a host of neuropsychiatric and 
neurodegenerative disorders[128]. Thus a method of labelling FABP7 in cells would 
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ABSTRACT     
Methods for the isolation of live neural stem cells from the brain are limited due to 
the lack of well-defined cell surface markers and tools to detect intracellular markers. 
To date most methods depend on the labelling of extracellular markers using 
antibodies, with intracellular markers remaining inaccessible in live cells. Using a 
novel intracellular protein FABP7 (Fatty Acid Binding Protein -7) selective 
fluorescent chemical probe CDr3, we have successfully isolated high FABP7 
expressing cells from the embryonic and adult mouse brains. These cells are capable 
of forming neurospheres in culture, express neural stem cell marker genes and 
differentiate into neurons, astrocytes and oligodendrocytes. Characterization of cells 
sorted with Aldefluor or antibodies against CD133 or SSEA-1 showed that the cells 
isolated by CDr3 exhibit a phenotype distinct from the cells sorted with conventional 
methods. FABP7 labelling with CDr3 represents a novel method for rapid isolation 






MATERIALS AND METHODS 
Brain cell preparation 
For the preparation of cells from the embryonic and adult mouse brains, E14 embryos 
and brains from 8-12 week old adults were used. For embryos, the whole embryo 
brain was dissected out and digested in 0.25% trypsin-EDTA (GIBCO) for 15 
minutes at 37 ⁰C. To achieve a single cell suspension, the trypsin was neutralized 
with FBS and the brains were resuspended in PBS before sequential trituration using 
pipettes of decreasing diameter. Cell suspensions were washed three times in PBS 
before filtering through a 40 µm strainer. For the adult brain, whole brain without 
cerebellum was dissected and minced in 20 U/mg of papain solution (Worthington) 
for 1 hour at 37 ⁰C before trituration and washing as described above. Animals were 
prepared and sacrificed in accordance with the protocol approved by the Institutional 
Animal Care and Use Committee. 
Cell sorting and flow cytometry 
Embryonic and adult brain cells were stained for 1 hour with 500 nM of CDr3 in 
neurosphere growth media consisting of DMEM/F12, B27 without vitamin A, bFGF 
(10 ng/ml) and EGF (20 ng/ml) (GIBCO) and penicillin-streptomycin glutamine 
before sorting using the MoFlo XDP (Beckman Coulter). For AldeFluor staining, we 
used the AldeFluor
TM
 kit (STEMCELL Technologies) according to the 
manufacturer’s instructions. Labelled single cell suspensions were pre-gated for size 
and granularity before sorting based on their relevant fluorescence marker. For 
immunostaining and sorting, cells were stained with CD133 (Biolegend, 1:250) and 
SSEA-1 (Millipore, 1:250) antibodies for 1 hour followed by secondary antibody 
conjugated to Alexa Fluor 488 (Life Technologies). For flow cytometry analysis, the 
primary antibodies against CD133 (Biolegend), SSEA-1 (Millipore), FABP7 
(Abcam) and ALDH1A1 (Santa Cruz) were diluted 1:500 to stain. Flow cytometry 
analysis was carried out on a BD LSRII analyzer. All sorting experiments were 
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carried out n = 3-5 times with the data shown reflecting the data from one 
representative independent experiment.  
Neurosphere assay and differentiation 
Embryo and adult derived neurospheres were grown in DMEM/F12 supplemented 
with B27 without vitamin A, 20 ng/ml of EGF, 10 ng/ml of bFGF and penicillin-
streptomycin glutamine and cultured for 4-5 days (embryo) or 5-7 days (adult). For 
neurosphere assay cell sorting, a total of 10,000 cells were plated per well of a six 
well plate in neurosphere growth media. Samples were plated in triplicate and the 
neurospheres were counted 4-5 days (embryo) or 5-7 days (adult) later. To assess 
differentiation capacity, neurospheres were differentiated on poly-D-lysine (Sigma) 
coated plates for 5 days in DMEM/F12 + 10% FBS (GIBCO) before fixation in 4% 
paraformaldehyde. To determine self-renewal for secondary, tertiary and further 
assays, primary assay neurospheres were pooled and triturated to a single cell 
suspension in 0.05 M NaOH followed by neutralization with 0.05 M HCl. The cells 
were then re-plated at a density of 1000-2000 cells per well in fresh neurosphere 
growth media.  
Neurosphere confocal imaging 
For whole neurosphere imaging, P1 neurospheres were dissociated and plated in 
growth media for 2 days in the presence of 500 nM of CDr3. For embryo derived 
brain cell imaging, whole brains from E14 embryos were triturated to a single cell 
suspension and stained for 1 hour in 500 nM of CDr3. All confocal imaging was 
carried out using the Zeiss LSM 510 Meta at 60X magnification. 
Neurosphere assay 
For non-sorted neurosphere assays from P1-P2 embryo derived neurospheres, 3000 
cells were plated per well in 0.1% DMSO or 500 nM CDr3 and incubated for 6 days 
before counting (Supplementary Figure 2). For adult neurosphere formation, the 
whole mouse frontal brain was divided into two halves – one half was triturated and 
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plated in entirety for neurosphere formation. The other half was stained with CDr3 
and sorted in entirety for neurosphere assay.  For quaternary and quinary neurosphere 
assays, due to the large number of spheres formed by tertiary assay – 100 µl of 
neurospheres was harvested per well at tertiary assay stage and dissociated for 
subsequent quaternary and quinary assay culture. Final numbers were calculated by 
multiplying by well volume and dilution factors. 
Adult brain dissection for neurosphere assay 
For brain dissection without sorting, one brain was halved and the cells from one 
hemisphere triturated to a single cell suspension and seeded in entirety in neurosphere 
growth media. The SVZ region from the remaining hemisphere was dissected out and 
also triturated into a single cell suspension before plating. After 6-10 days, the 
neurospheres formed from each region of the brain were counted. 
MTS assay 
For the measurement of cell proliferation by MTS assay (Promega), 100,000 cells 
were sorted with their respective markers (whole, CDr3, AldeFluor, CD133 or SSEA-
1) and re-cultured for 5-6 days to form neurospheres. Spheres were subsequently 
dissociated using 0.05 M NaOH treatment and plated in entirety in triplicate on a 96 
well plate. The addition of 20 µl of MTS reagent was added to the cell solution and 
the readings were measured at 490 nm after 4 hours incubation.  
Cell immunostaining  
For triple immunostaining of neurons, astrocytes and oligodendrocytes from 
differentiated neurospheres, cells fixed with 4% paraformaldehyde were first blocked 
in 1% BSA followed by O4 antibody staining (Millipore, 1:1,000) and secondary 
antibody staining (AlexaFluor 488, Life technologies). This was followed by 
permeabilization with 0.1% Triton-X and antibody staining with β-III-tubulin 
(Sigma) and GFAP (Wako) at 1:500-1:1,000 dilutions. For further secondary 
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antibody staining, AlexaFluor 546 and Cy5 conjugated antibodies (Life 
Technologies) were used respectively at dilution factors of 1:100. Images were 
acquired on the Nikon Ti microscope at 100X magnification.  
Gene expression analysis 
For the analysis of gene expression, RNA was extracted from whole, bright and dim 
FACS sorted cells using the QIAGEN RNeasy purification kit according to the 
manufacturer’s instructions. RNA samples were analyzed by qRT-PCR with the 
SYBR Green Master mix reagents (Applied Biosystems) with normalization to 
GAPDH expression. The full list of primers and their respective efficiencies are as 
indicated below: 
qRT-PCR primers 
Name Sequence (5’…3’) Primer efficiency 
(%) 
mGAPDH-F1 aagggctcatgaccacagtc 99.7 
mGAPDH-R1 ggatgcagggatgatgttct 
mFabp7-F1 ccagctgggagaagagtttg 99.5 
mFabp7-R1 tttctttgccatcccacttc 
mNestin-F1 ggaagaagttcccaggcttc 98.5 
mNestin-R1 attaggcaagggggaagaga 
mHes1-F1 acaccggacaaaccaaagac 97.2 
mHes1-R1 atgccgggagctatctttct 
mHes5-F1 gcagcatagagcagctgaag 93.8 
mHes5-R1 aggctttgctgtgtttcagg 
mSox2-F1 gaacgccttcatggtatggt 99.2 
mSox2-R1 tctcggtctcggacaaaagt 
mPax6-F1 agtgaatgggcggagttatg 97.5 
mPax6-R1 acttggacgggaactgacac 
mCD133-F1 tgcgatagcatcagaccaag 96.8 
mCD133-R1 tttgacgaggctctccagat 




















For whole neurosphere imaging, P1 neurospheres were dissociated and plated in 
growth media for 2 days in the presence of 500 nM of CDr3. For embryo derived 
brain cell imaging, whole brains from E14 embryos were triturated to a single cell 
suspension and stained for 1 hour in 500 nM of CDr3. All confocal imaging was 
carried out using the Zeiss LSM 510 Meta at 60X magnification. 
FACS sorting of cell populations 
Cells derived from the E14 embryo brain were labeled with CDr3, AldeFluor, CD133 
or SSEA-1. Populations of single or double positive cells that were clearly 
distinguishable within each marker range were sorted out for neurosphere assay and 
plated at a density of 5000 cells per 12 well plate. The number of spheres formed was 
counted after 4-6 days. 
Neuronal differentiation and tripotency testing 
To determine if CDr3 had any detrimental effects on the capacity of neural stem cells 
to differentiate into neurons, P1 neurospheres were dissociated into a single cell 
suspension and induced to differentiate in DMEM/F12 + 10% FBS media 
supplemented with 1X B27 and 50 ng/ml of BDNF (GIBCO) on poly-D-lysine coated 
plates in DMSO or 500nM of CDr3. After 5-7 days of differentiation, the cells were 
fixed with 4% paraformaldehyde and immunostained for β-III-tubulin (Sigma) and 




magnification. The total number of astrocytes and neurons were counted per region. 
The average yield of neurons was calculated from a total of 10 regions with an 
average of approximately 50 cells per region.  
 
RESULTS 
High FABP7 expressing cells from the embryonic and adult brain form 
neurospheres  
FABP7 is expressed in a large population of cells in the developing embryo brain but 
only constitutes about 1% of the brain cell population by adulthood [73]. CDr3 
staining could be visualized in culture where certain cells in neurospheres and 
dissociated brain cells appeared much more brightly stained than their surrounding 
cells (Figure 5.3.1a). When applied to mixtures of primary embryonic and adult 
mouse brain cell preparations, CDr3 was sufficiently specific for the clear 
identification of a distinct population of primary brain cells (Figure 5.3.1b). As such 
we were interested to determine if high FABP7 expression alone (as gated by the 
brightest 10% of CDr3 positive cells – Figure 5.3.1b) was sufficient for the isolation 
and characterization of NSCs from the brain.  
For assessment of self-renewal capacity, the brightest and dimmest 10% of the CDr3 
positive cell populations from E14 embryonic mouse brains were sorted out and 
plated for neurosphere assay. CDr3
Bright
 cells were highly proliferative compared to 
their CDr3
Dim



























Figure 5.3.1. (a) Confocal microscope images of CDr3 stained embryo brain primary 
cells. The yellow arrow indicates CDr3
Bright
 cells. Scale bar, 20 µm. (b) Scatter 
profile of FABP7 and CDr3 stained cells. For both embryo and adult brain derived 
cells, live cells were pre-gated with size and granularity (Left). A distinct population 
of CDr3 positive cells were identified by fluorescence (Middle). For sorting, the 
brightest and dimmest 10% of the cells were gated based on a histogram plot (Right). 
(c) Number of neurospheres generated from unsorted (whole) and sorted embryo 
brain cells by CDr3, AldeFluor, CD133 antibody and SSEA-1 antibody. The sorting 
was carried out n=5 times with the data reflecting the best yield from one independent 
experiment. An unpaired two-tailed t test was performed (whole vs. bright, 
**p<0.01). (d) Size of neurospheres generated from sorted embryo brain cells by 
CDr3, Aldefluor, CD133 antibody and SSEA-1 antibody. (e) An MTS assay was 
performed on cell dissociated from unsorted (whole), CDr3, AldeFluor, CD133 and 
SSEA-1 sorted neurospheres. An unpaired, two tailed t test was performed (whole vs. 
sorted, *p<0.05, **p<0.01). Values shown represent mean ±S.D. 
When compared to the unsorted (whole) fraction, CDr3 NSC enrichment resulted in 
an up to 5 fold increase in neurosphere yield which was comparable to established 
methods of neurosphere enrichment by cell sorting using AldeFluor or antibodies 
against CD133 and SSEA-1 in number (Figure 5.3.1c) and size (Figure 5.3.1d) of 
neurospheres when applied to embryonic mouse brain cells. Because neurospheres 
themselves cannot be considered clonal entities [120], an MTS assay was also carried 
out to measure the proliferative activity of the isolated cells (Figure 5.3.1e). All 
marker-sorted cells were significantly more proliferative compared to the whole 




High capacity for self-renewal is characteristic of NSCs as opposed to neural 
progenitors, which lose their self-renewal capacity after several passages. CDr3 
sorted NSC from the embryo and adult brain were successfully serial passaged at a 
yield that was higher than that of neurospheres generated from unsorted cells (Figure 
5.3.2a and b). A comparison of neurospheres grown in 500 nM of CDr3 and 0.1% 
DMSO containing media showed that the dye does not affect the ability of the cells to 
form spheres (Figure 5.3.2c and d). 
 
Figure 5.3.2. Neurosphere growth and size.  Neurospheres generated from embryo 
(a) and adult brain (b) was serially passaged and the number of spheres counted at 
each passage. CDr3 treated spheres were comparable in sphere size (c) and number 
(d) with vehicle (0.1% DMSO) treated spheres. An unpaired two tailed t test was 
performed (* p<0.05 and **p<0.01) for mean values. Values shown represent mean 
±S.D. For box plot distribution, a Mann-Whitney U test was performed.  
CDr3 enriches for NSCs in the adult brain 
Adult NSCs are far fewer and have more restricted growth conditions as compared to 
embryo derived cells [111]. In adult brain cell preparation, there is also considerable 
amount of myelin and cell debris, which makes cell isolation difficult (Figure 5.3.3a). 
The sub ventricular zone (SVZ) of the adult brain is known to harbour the highest 
percentage of NSCs and is thus usually the region of choice when isolating adult 
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NSCs to reduce complexity of the tissue. We compared the number of primary 
neurospheres generated from a whole hemisphere versus the dissected SVZ region of 
the other hemisphere from the same brain. Our data showed that the SVZ accounts for 
up to 50% of the neurospheres formed from one hemisphere of the brain. However, a 
significant portion of neurospheres can also be derived from the remaining regions of 
the brain. Thus by dissecting only the SVZ, up to 50% of neurosphere yield from the 
brain is lost which is considerable given the relative scarcity of NSCs in the adult 
brain. CDr3 enrichment provided a much cleaner cell preparation of adult brain 
derived neurospheres, which were bigger and could be used for further experiments 
(Figure 5.3.3a and b). Compared to AldeFluor, CDr3 sorting generated higher levels 
of enrichment (Figure 5.3.3c). Attempts to sort cells from the whole adult brain by 
CD133 and SSEA-1 antibody sorting failed to produce any spheres in culture. 
 
Figure 5.3.3. (a) Neurospheres generated from unsorted and sorted cells isolated 
from embryo and adult brains. Scale bar, 20 µm. (b) Size of neurospheres generated 
from unsorted (whole) and sorted adult mouse brain cells by CDr3. A Mann-Whitney 
U test was performed where **p<0.01. (c) Number of neurospheres generated from 
unsorted (whole) and sorted adult mouse brain cells by CDr3 and Aldefluor. CDr3 
yielded a significantly higher number of neurospheres (**p<0.01) compared to 
Aldefluor. Values shown represent mean ±S.D.  
CDr3 isolated neurospheres are multipotent and express high levels of NSC 
genes 
NSCs are capable of differentiating into all three neural cell types i.e. neurons, 
astrocytes and oligodendrocytes, whereas neural progenitors have a more restricted 
differentiation lineage [110]. CDr3 isolated neurospheres from both embryonic and 
adult brains could be effectively differentiated into all three cell types (Figure 5.3.4a), 
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with robust staining for their respective antibody markers. This potential for multi-
lineage differentiation validates their NSC phenotype.  
 
Figure 5.3.4. (a) CDr3 sorted primary neurospheres from the E14 embryo and adult 
brains were differentiated and immunostained for β-III-tubulin (neurons), GFAP 
(astrocytes) and O4 (oligodendrocytes). Scale bar, 20 µm. (b) Expression of neural 
stem cell associated genes in unsorted (whole) and sorted embryo and adult brain 
cells by CDr3. An unpaired two-tailed t test was performed for all genes (* p<0.05 




In addition to FABP7, there are numerous other gene markers that are known to be 
distinctively expressed in NSCs [102, 107, 108]. For the gene expression analysis, we 
used 8 different gene markers for analysis of the cell populations isolated from the 
embryo and adult brains. CDr3
Bright
 cells were found to have higher expression of 
FABP7 compared to CDr3
Dim 
cells in both embryo and adult sorted cells. This is 
consistent with the dye’s FABP7 selectivity (Figure 5.3.4b). In addition, CDr3Bright 
cells also showed high expression of other known NSC markers such as Nestin, Hes1 
and Hes5. Pax6 expression was too low to be detected in the adult brain. Comparison 
of unsorted (whole) versus CDr3
Bright
 samples also showed that CDr3 sorting 
significantly enriched for high FABP7 expressing cells up to from 2-20 fold 
compared to unsorted embryo derived brain cells (Figure 5.3.4b). This confirms that 
CDr3 is effective for use as a sorting tool for the isolation of NSCs from the 
embryonic and adult brains. 
CDr3 was shown to not impede the differentiation capacity of embryo brain derived 
neurospheres compared to DMSO, with a large percentage of neurospheres exhibiting 
tripotency as observed from their ability to differentiate into neurons, astrocytes and 
oligodendrocytes (Figure 5.3.5a and b). To demonstrate that CDr3 does not affect the 
ability of neural stem cells to differentiate into neurons, which would potentially 
impede neurogenesis, neurospheres were dissociated into single cells and induced to 
neuronal differentiation in the presence and absence of CDr3. There was no 
significant difference in the number of neurons generated from DMSO and CDr3 






Figure 5.3.5. (a) Embryo derived neurospheres were differentiated in the presence of 
DMSO or 500 nM of CDr3 and tripled immunostained for β-III-tubulin/neurons 
(yellow), GFAP/astrocytes (red) and oligodendrocytes O4/oligodendrocyes (green). 
Scale bar; 50 µm. (b) The pie charts show the percentage of uni-, bi- and tripotent 
neurospheres in DMSO and CDr3 treated embryo brain derived neurospheres 
respectively as determined by tripled immunostaining. Numbers shown are a 
representative of 50 spheres. (c) The left shows representative images of neurons/β-
III-tubulin (green) and astrocytes/GFAP (red) differentiated from single cells 
dissociated from neurospheres treated with DMSO and CDr3. Scale bar, 50 µm. The 
bar graph shows the percentage yield of neurons from DMSO and CDr3 treated 
dissociated spheres. An unpaired two tailed t test performed shows no difference in 
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High FABP7 isolated NSCs constitute a unique phenotype 
Due to its intracellular localization, FABP7 is seldom used for cell isolation. With the 
development of CDr3 as a live NSC probe, we are now able to characterize these 
cells based on their level of FABP7 expression alongside other cell surface markers 
such as CD133 and SSEA-1. It is interesting to note that while the fluorescent probe, 
AldeFluor has been successfully employed for the use of NSC isolation [108], its 
representative binding target – ALDH1A1 is not generally known to be a marker for 
NSCs. Moreover, recent studies have shown that this protein may in fact be 
dispensable for stem cell function [131].  
To characterize the brain cells by their respective phenotypes, cells derived from the 
whole E14 embryo and adult mouse brains were stained and sorted by CDr3, SSEA-
1, CD133 or AldeFluor. Live cells collected by sorting were then co-labelled with 
another NSC marker (CDr3, AldeFluor, CD133 or SSEA-1) and analyzed by flow 
cytometry to determine the percentage of cells expressing each NSC marker. It was 
observed that marker profiles at E14 and adult stage were distinct. CD133 and SSEA-
1 occupied relatively selective niches at E14 but their expressions expanded to 
encompass a greater proportion of other cells by adult stage (Figure 5.3.6a, Table 
5.1).  
Table 5.1.The respective marker expression in embryo (a) and adult (b) brain cell 
populations was characterized by flow cytometry. The shaded sorting marker column 
indicates the marker in which the cells were sorted by and the unshaded column 





Figure 5.3.6. (a) The percentage of marker sorted cells from embryo brain or adult 
brain expressing other markers measured by flow cytometry. The live cells were co-
labelled with CDr3, AldeFluor, CD133 antibody and SSEA-1 antibody and plotted 
on a radar plot to illustrate the spread of marker expression when each population was 
limited to sorting by a particular marker. 
Although CDr3 was not the most restricted lineage at E14 stage, expression area was 
markedly reduced in the adult, especially in the proportion of CD133 positive cells. 
This is consistent with published literature and our own results (Figure 5.3.6), which 
demonstrate that CD133 expression is decreased in the adult versus embryo stage. 
This suggests that CD133 may no longer be a strong NSC marker in the adult mouse 
brain.  AldeFluor appeared to be the widest marker, with little change from E14 to 
adult (Figure 5.3.6a, Figure 5.3.7). This suggests that while it is capable of isolating 




Figure 5.3.7. CD133 and ALDH1A1 gene expression in cells from the embryo and 
adult brain. CD133 expression is robust in the embryo brain but less so in the adult 
brain. ALDH1A1 expression levels were similar in both the embryo and adult brains 
for AldeFluor sorted cells. An unpaired two-tailed t test was performed (* p<0.05 and 
**p<0.01). Values shown represent mean ±S.D. 
Embryo brain cells were also sorted using AldeFluor or CD133 antibody and 
analyzed for FABP7 and ALDH1A1 gene expression. While both AldeFluor and 
CD133 positive cells in the embryo brain expressed high levels of FABP7, CD133 
positive cells were found to express lower levels of ALDH1A1 than negative cells 
(Figure 5.3.8a). For live-sorted cells, CDr3
Bright
 cells showed high CD133 expression 
(Figure 5.3.8a) but low AldeFluor staining (Figure 5.3.8b). An analysis of CDr3
Bright
 
embryo brain cells immunostained with ALDH1A1 antibody showed that ALDH1A1 
positive cells only constitute about 10-20% of CDr3 bright sorted cells (Figure 
5.3.6c).  
 
Figure 5.3.8. Gene expression in embryo and adult brain cells sorted by CD133, 
AldeFluor and CDr3. AldeFluor (a) and CD133 (b) sorted cells from the embryo 
brain were compared for Fabp7, nestin, CD133 and ALDH1A1 expression. An 
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unpaired two-tailed t test was performed for bright and dim sorted cells (* p<0.05). 
Values shown represent mean ±S.D. 
To further assess the importance of each marker in conjunction with one another, 










 cells formed few spheres (37 spheres) (Table 5.2).  
Table 5.2: Neurosphere yield from sorted subpopulations of marker labeled E14 
embryo brain derived cells. 
 
This underscores the importance of both CD133 and SSEA-1 as NSC markers in the 
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.  However the inclusion or 
exclusion of AldeFluor as a sorting marker to SSEA-1+ and CD133+ did not appear 
to influence sphere yield significantly. Including CD133 alongside CDr3 improved 






While FABP7 has been shown to be expressed in NSCs, it has not been used for live 
NSC isolation from a mixture of various types of cells largely because of its 
intracellular nature, which necessitates cell permeabilization and hence cell death in 
the process of detection using antibodies. In this study, we demonstrated that the 
availability of CDr3 as an intracellular live NSC probe now makes it possible to 
isolate NSCs by the expression of FABP7.  
To date, CD133 remains the most established NSC marker for immunoseparation of 
NSCs from brain tissue [102, 107]. The importance of CD133 is highlighted in the 
fact that almost all cells positive for other markers show strong CD133 expression 
and that the inclusion or exclusion of CD133 as a marker from CDr3 positive 
populations strongly influences sphere yield. Our data has shown that CD133 
expression in the embryonic brain is generally high (Figure 5.3.6, Figure 5.3.7). But 
little CD133 expression was detected in the adult brain which is in agreement with 
data reported by Pfenninger et.al [113]. Interestingly, the proportion of CD133 
expressing cells within the CDr3 population fell from embryo to adult but expanded 
across other markers. This represents a drawback of the use of CD133 as a NSC 
marker in the adult brain and suggests that its role as a NSC marker differs depending 
on the age.  
AldeFluor is a small molecule dye which has been shown to be able to isolate NSCs 
from the brain [108]. Compared to CDr3, it requires more preparation such as dye 
activation and blocking of the ABC transporter [132]. Its binding target in stem cells 
has been shown to be aldehyde dehydrogenase (ALDH1A1) [109].  However only 
10% of high FABP7 expressing cells were ALDH1A1 positive and its expression 
appeared to be broad ranging in both the embryo and the adult. The higher percentage 
of ALDH1A1 expressing cells in the dim fraction of CD133 sorted cells also suggests 
that the ALDH1A1 positive population is underrepresented or absent in the CDr3 
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positive cell fraction and that the three markers (FABP7, CD133 and ALDH1A1) 
may not be co-expressed in the major population of NSCs. Neurosphere yields from 
AldeFluor sorted adult brain cells were also lower than that from CDr3 sorting, and 
the inclusion of Aldefluor as a subpopulation marker did not affect neurosphere yield 
significantly. This suggests that while some NSCs may express elevated levels of 
ALDH1A1; this expression is not a critical marker of NSC property. This could 
largely in part be due to the presence of alternative ALDH isoforms present in mouse 
NSCs [132].  
It was also observed that the expression of Nestin, Hes1 and Sox2 in CDr3
Bright 
adult 
sorted cells were lower than the unsorted fraction or largely unchanged. Studies have 
shown that it is likely that multiple classes of neural stem/progenitor cells exist, each 
classified by distinct gene expression profiles. A study by Hendrickson et al., 2011 
has found that four distinct classes of nestin expressing cells exist in the mature adult 
brain, one of which consists of a class of terminally differentiated neurons [133]. This 
suggests that the expression of nestin alone may not be a reliable indicator of neural 
cell stemness in the adult brain and may account for the lack of nestin enrichment in 
CDr3
Bright
 sorted adult brain cells. In another study by Hutton and Pevny, the authors 
have also found that Sox2 is differentially expressed between neural progenitors and 
intermediate progenitor populations [134]. In the study by Obermair et al.[112], Sox2 
expression in CD133, SSEA-1 or ALDH positive cells isolated from adult mouse 
brain subventricular zone is lower than in the marker-negative cells. And even 
between CD133 positive cells, Sox2 expression level dramatically varies depending 
on the region where the cells are isolated. This suggests high FABP7 expressing 
neural stem cells may represent an alternative class of adult neural stem cells that 
retain neural stemness while expressing a unique neural stem cell gene profile.   
NSC isolation from the adult mouse brain is more challenging given the vast amount 
of white matter and glia packaging the brain. Most NSC isolation protocols require 
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additional purification steps prior to NSC sorting such as SVZ dissection or density 
centrifugation to remove myelin debris [73, 102, 106]. In the case of CDr3, we were 
interested to show if the compound was specific enough to isolate NSCs without the 
need for additional purification steps. When NSCs were isolated from the whole adult 
brain using the different methods and cultured for neurosphere assay, the largest 
number of neurospheres was generated from the cells isolated by CDr3, while no 
spheres were formed from CD133 and SSEA-1 antibody sorted cells. Failure of these 
antibody-based isolation methods is likely due to lower expression of these genes in 
adulthood (Pfenninger et al., 2007). In the absence of a single defined NSC marker, 
several research groups have attempted to classify their observations into different 
sub populations of NSCs based on marker expression and differentiation potential. 




 cells are tripotent among 


















 formed a very slowly dividing subtype of 



















The heterogeneity of marker expression in these isolated cells and its changes over 
development suggest that a more comprehensive characterization of these cells is 
required for an understanding of their regenerative potential, for which the inclusion 





We have demonstrated that CDr3 can be reliably used as a marker for the isolation of 
NSCs from whole embryonic and adult brain tissue based on specific binding to the 
intracellular protein, FABP7. This is unique because most existing NSC isolation 
methods utilize extracellular markers. The inclusion of FABP7 as an additional 
isolation marker may shed more light on the characteristics of the NSC phenotype, 
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6.1 Milestones of the DOFL approach 
Our original aim was to develop fluorescent small molecule cell type specific probes 
for cells of the mouse brain using the concept of the Diversity Oriented Fluorescence 
Library (DOFL). Our hypothesis was that combinatorial diversity of different side 
chains on fluorophore scaffolds would generate structures with intrinsic specificity 
for cell type specific targets in neural cells. This was successfully achieved by the 
development of the neuron and microglia probes, NeuO [135] and CDr10 [136] 
respectively as well as the neural stem cell selective probe CDr3[24]. Several other 
cell type specific probes for other cell systems have also been developed from DOFL 
for a range of in vitro and in vivo applications[65, 137]. 
To date the DOFL consists of up to 15,000 compounds, with diverse scaffolds and 
colours to select from. The versatility of these small molecule probes, tunability and 
the ease of application to a wide range of cellular systems remain the strongest selling 
point for probe development. However, the design of effective screening platforms 
and model systems remains a critical starting point for all probe discovery methods, 
exemplifying the ‘you get what you screen for’ adage. The types of applications for 
which these dyes are suited for are also highly dependent on the physicoproperties of 
the dyes, some of which may be better suited to in vitro or in vivo applications. 
Limitations to small molecule dye staining include the common observation of high 
background in the image, particularly within cells due to the inability to wash out the 
unbound probe from within the cell. Results may also differ among different cell 
types.   
The DOFL approach has been successfully applied to neural stem cells [24, 121], 
microglia [136] and neurons [135]. There are also continual efforts to develop small 
molecule fluorescent probes for astrocytes and oligodendrocytes as well as neuronal 
subtype specific dyes in different colours so as to complement their combinatorial 
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use. Accurate target identification and validation remains an ongoing challenge in our 
DOFL approach. This reflects a limitation in the bottom up approach whereby 
binding targets may not be so easily discerned. In the case of CDr10 and NeuO, there 
appeared to be multiple binding targets which made clear target validation difficult. 
Having a single candidate binding target from protein analysis and mass spectrometry 
identification methods vastly improves the chances of successful target validation.  
6.2 Potential for further development 
Due to their small size and ease of tunability, small molecule fluorescent probes have 
great potential for further development for a multitude of applications. Their uses are 
not confined to fluorescence labelling and detection methods but can be applied for 
other uses if the active binding sites conferring specificity can be identified. For 
example, the arms of the NeuO mother compound have been identified as the critical 
neuron specific binding motifs. Thus neuron specific compound structures can be 
designed for other neuron targeting purposes such as drug delivery or cell labelling. 
This makes them further applicable to a variety of in vitro and in vivo uses. Similarly, 
the stable and transient variants of CDr10 can be applied for the development of in 
vitro inflammation detection assay, whereby fluorescence may be used a reporter of 
cell activation status and immune activity. Additional applications for cell type 
specific isolation alongside other markers, such as that demonstrated by CDr3 may 
also be developed according to the desired output as required by the user.  
As discussed earlier, our small molecules probes may be modified into in vivo 




F. This is applicable for probes like CDr10 and NeuO respectively which have been 
shown to have BBB permeabilising properties and can thus be developed for 
diagnostic molecular imaging modalities. The flexibility of their selected structural 
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arms may also allow for conjugation of other drug molecules for cell type specific 
targeting therapies. 
Application to disease modelling 
Our dyes have thus far been developed in wild type mouse neural cells that are 
representative of healthy neural cells and identified by their characteristic staining 
patterns and phenotypes. It would be interesting to test them in areas of 
neurodevelopmental and neurodegenerative disease modelling whereby they may be 
used to monitor and identify morphological and biochemical signs of disease. They 
may also be used in conjunction with drug screens that may be used to identify 
potential hit compounds that may be used to reverse of alter the observed disease 
phenotype (Figure 6.2.1). Both NeuO and CDr3 have been found to exhibit 
specificity for their respective cell types in mouse and human tissues respectively, 
thus making them suitable for translational disease modelling studies.  
  
Figure 6.2.1 Illustration of disease modelling using cells differentiated from hESCs. 
The rightmost image shows the complex interactions between multiple neural cells as 
illuminated by antibody staining. Images author’s own. 
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Emerging technologies that support live cell imaging 
A key advantage of small molecule fluorescent probes lies in the ability to achieve 
live cell imaging, enabling us to capture cellular activity over minute spaces and time 
scales. However in order for this to be successfully achieved, fluorescence imaging 
systems also have to be sensitive and efficient enough to capture these changes. 
Neural cells and neurons in particular are very sensitive to phototoxicity and care has 
to be taken so as not photobleach the dyes or kill the cells in the process of long 
duration time lapse imaging.  
Several new technologies have emerged with precisely the above mentioned 
specifications, one of which to note is Selected Plane Illumination Microscopy 
(SPIM). SPIM employs the use of a single light sheet to illuminate the sample from 
multiple angles, with the sample rotated during imaging so as to produce a 3D image 
of remarkable high resolution. Due to the thinness of the light sheet, photobleaching 
and phototoxicity is very minimal thus making possible to image developing embryos 
real time. Single molecule imaging, which increases image resolution by capturing 
the signals from individual fluorphores has also become increasingly popular 
although it is yet to be established if our dyes are suitable for these purposes. 
Another possibility which has yet to be thoroughly explored is the combination of one 
or more dyes of different colours to achieve multi-colour live cell imaging. This 
enables one to study the interactions between different cell types simultaneously. In 
tissues such as the brain where the cells are densely packed and heterogenous, the use 
of suitable tools and imaging techniques are critical in obtaining high quality data, 






6.3 Final Conclusion 
The Diversity Oriented Fluorescence Library screening approach has been 
demonstrated as an effective method for the development of live neural cell type 
specific fluorescent probes. We have designed a primary neural cell screening 
platform for the identification of the neuron and microglia specific probes, NeuO and 
CDr10 and validated their specificity to their respective cell types. Comprehensive 
studies on dye binding properties and cell characterization have also been carried out, 
with the identification of several key applications for which they can be used. For 
example CDr3, the FABP7 binding dye which was previously identified to be neural 
stem specific was further developed as a neural stem cell isolation probe for the 
isolation of neurospheres from primary embryo and adult tissue.  
The versatility of our dyes makes them suitable for a wide variety of cell labelling 
and imaging applications, for which only a few have been explored. Their ability to 
label live cells makes it possible to observe cellular interactions real time – a 
modality that is becoming increasingly popular with the advent of more advanced 
microscopy technologies. The identification of molecular targets and combination for 
functional read outs would also represent a development in cell assay design. In the 
long run, it may also be possible to develop cell type specific targeting therapies by 
the conjugation of drug molecules to suitable regions of the small molecules. 
The field of Chemical Biology is an exciting and rapidly developing area of research 
that combines the best of chemistry and biology to create an integrated platform for 
our understanding of cell labelling and probe development. Our discovery of neural 
cell specific small molecules and their application and use by other researchers will 
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Figure 8.1.1. Primary microglia stained by the other microglia specific hits 
and immunostained by the microglia marker, Iba. Scale bar; 50 µm.  
Iba BDD1 G3 Iba 
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8.1.3 Chemical synthesis and NMR 
*CDr10 chemical synthesis and NMR information is courtesy of Dr. Lee Sung Chan 







 D A D 1  D , S ig= 560 ,16  R e f= o ff (D :\D A TA \LS C 2 \B D N C A 1H 5 .D )
 
 










 DAD1, 3.925 (171 mAU, - ) of BDNCA1H5.D







* M S D 1  S P C ,  t i m e = 3 . 9 3 5  o f  D : \ D A T A \ L S C 2 \ B D N C A 1 H 5 . D     E S - A P I ,  P o s ,  S c a n ,  F r a g :  1 5 0 ,  " E S  p o s i t i v e "
M a x :  2 2 3 2 3 2
 4 2 9 . 4  6 9 9 . 6
 3 6 8 . 4
 5 2 9 . 2
 5 4 8 . 2
 5 3 2 . 2
 5 5 0 . 2
 5 3 0 . 2
 
 
Figure 8.2.1a.  LC-MS spectrum of CDr10.  HPLC condition: column (5 m, C18, 
50 x 4.6 mm), 0.1 % TFA acetonitrile/water gradient from 5 to 100 % with 5 min 














Figure 8.2.1b. 500MHz, 1H, 13C-NMR spectrum of CDr10(CDCl3). The upper 
panel shows UV absorption and the lower panel shows single quadruple mass 




8.1.3 Supplementary video legends 
Supplementary video 3.2.1. (Page 50)   
BV2 microglia were stained with 500 nM of CDr10b and imaged using time lapse 
microscopy over a duration of 12 hours at intervals of 10 minutes. The cells divide 
normally in the presence of the dye. 
Supplementary video 3.2.2. (Page 53) 
The video shows BV2 microglia actively moving around and phagocytosing 
neighboring cells. The faster and more actively moving microglia involved in 
phagocytosis appear to be more brightly stained by CDr10b than the less active 
microglia cells. 
Supplementary video 3.2.3. (Pg 54) A mixed culture of primary neural cells were 
stained with 500 nM of CDr10b and imaged for 24 hours. CDr10b positive 
microglia cells are seen ‘searching’ other primary neural cells for cell signaling cues. 
Supplementary video 3.2.4. (Pg 54) To monitor the activity of activated BV2 
microglia on dying cells, U251 glioma cells were treated with 10 µM of camptothecin 
before labeling with CellTracker green (Life technologies). This was followed by the 
addition of BV2 microglia labeled with 500 nM of CDr10b.  Cells were imaged at 
20X magnification for 36 hours. Several compound labeled microglia (red) can be 







8.2.1 Chemical synthesis and NMR  *Data courtesy of Er Jun Cheng 
3-(benzylamino)-4,4-difluoro-5-(4-propyl-1H-1,2,3-triazol-1-yl)-8-(4-(2-
hydroxyacetamido)phen-yl)-4-bora-3a,4a-diaza-s-indacene (NeuO) (3) (4.2 mg, 
7.57 mol, 36% yield); 1H NMR (500 MHz, Acetone-d6) δ 9.36 (s, 1H), 8.14 (s, 1H), 
7.97 (s, 1H), 7.95 (d, J = 8.6 Hz, 2H), 7.52 (d, J = 8.6 Hz, 2H), 7.43 (d, J = 7.6 Hz, 
2H), 7.37 (t, J = 7.6 Hz, 2H), 7.29 (t, J = 7.3 Hz, 1H), 7.11 (d, J = 5.1 Hz, 1H), 6.67 
(d, J = 5.2 Hz, 1H), 6.51 (d, J = 3.8 Hz, 1H), 6.44 (d, J = 3.8 Hz, 1H), 4.96 (s, 1H), 
4.87 (d, J = 6.5 Hz, 2H), 4.15 (s, 2H), 2.74 (t, J = 7.6 Hz, 2H), 1.75 (tq, J = 7.6, 7.4 
Hz, 2H), 1.02 (t, J = 7.4 Hz, 3H); 13C NMR (126 MHz, Acetone-d6) δ 171.5, 164.0, 
147.4, 140.7, 139.3, 137.3, 136.7, 135.1, 132.2, 131.9, 131.3, 129.9, 129.7, 128.5, 
127.9, 124.1, 120.1, 118.5, 114.9, 109.6, 63.1, 55.0, 28.3, 23.5, 14.2; 
19
F NMR (282 
MHz, Acetone-d6):  -144.84 (q, J = 33.8 Hz); 
11
B NMR (160 MHz, Acetone-d6): δ 







8.2.2 Supplementary video legends 
Supplementary video 4.2.1. (Page 85) This time lapse image shows the dendrite and 
axon formation of a freshly plated DIV0 neuron isolated from a P1 mouse neonate 
stained with NeuO. The cell is seen to be extending their dendrites in culture thus 
demonstrating that the presence of use dye has no adverse effects on neuron dendrite 
development in vitro.  
Supplementary video 4.2.2. (Page 85) Neurospheres were induced to differentiate to 
neurons in the presence of NeuO and time lapse imaged over 8 hours. Neurons can be 
seen emerging from the sphere and migrating throughout.  
Supplementary video 4.2.3. (Page 86) This video shows a culture of mature primary 
neurons actively forming processes in culture in the presence of NeuO staining. 
*Video courtesy of Dr. Yoon MH. 
158 
 
8.2.3 Time course in vivo studies 
 
 
Scale bar; 25 µm at 4X magnification, 100 µm at 10X magnification 
 
 
 
 
 
